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ABSTRACT

The bath-to-cell transport, cytosolic concentration, and tubular content of methylmercury
(Me203Hg+) and the sulfhydryl-amino acids and sulfhydryl-amino acid derivatives conjugated to
Me203Hg+ were studied in the non-perfused S2 segments of the proximal tubule of the rabbit
kidney. Active transport of Me203Hg+ was established by a temperature dependent (greater than
100% reduction in bath-to-cell transport, 99% decrease in cytosolic concentration, 63% decline
in the tubular contents at 12°C when compared to 37°C). Conjugates of Me203Hg+ showed
mixed results, with L-cysteine and L-taurine demonstrating the most significant increase in
uptake. Transport of Me203Hg+-L-cysteine was also temperature dependent with a 77% reduction
in bath-to-cell transport, 76% decrease in cytosolic concentration, and 86% decline in tubular
contents at 12°C when compared to 37°C. A significant decrease in transport was seen with the
classic organic anion transport (OAT) inhibitors of PAH (71% and 67%) and probenicid (48%
and 38%), as well as, the dicarboxylates, adepate (over 100%) and glutarate (69% and 52%) in

both bath-to-cell and cytosolic concentration respectively. The addition of L-methionine to the
Me203Hg+-L-cysteine conjugate significantly reduced the bath-to-cell transport by 64% and the
cytosolic contents by 47%. The Me203Hg+-L-taurine conjugate also demonstrated temperature
dependence (99% reduction and 91% decrease in bath-to-cell and cytosolic concentration
respectively, at 12°C when compared to 37°C). Inhibition with PAH was also seen (77%
reduction) in bath-to-cell transport and 67% decline in cytosolic concentration giving further
evidence to the transport of the Me203Hg+-L-taurine conjugate via OAT. When Me203Hg+ was
conjugated to L-methionine a 55% reduction in bath-to-cell transport was seen which was also
temperature dependent (59% decrease at 12°C when compared to 37°), although no significant
decrease in transport was noted with the addition of PAH. Analysis of the methylmercury
conjugates via mass spectrometry demonstrated that L-cysteine, L-taurine, and L-methionine all
are binding with methylmercury in the same unknown common configuration (MW=409).
These results indicate the mercuric conjugate is gaining entry into the renal epithelial cells via
the OAT and the amino acid transport system in the basolateral membrane of the proximal
tubule.
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CHAPTER I: INTRODUCTION

Methylmercury (Me203Hg+), an organic form of mercury is a highly toxic heavy metal, a
common environmental pollutant and continues to pose appreciable health risks to humans even
today. The inorganic form of mercury, Hg, enters the environment from such natural processes
as emissions from the earth’s crust and through man-made sources, mostly industrial pollution
(Figure 1). In the United States, coal-burning power plants account for the largest source of
unregulated mercury emissions (Management, 2003). The elemental form of mercury can then
be methylated by algae and bacteria in water and soil which can then move up through the food
chain via bioaccumulation, especially in aquatic species of fish (Figure 1). Methylmercury is of
particular concern as a pollutant in seafood as fish and other seafood products are the main
source of Me203Hg+ in the human diet (Aschner and Syversen, 2005). Consumption of
contaminated seafood accounts for the majority of the exposure to humans. Methylmercury is
considered to be the most toxic and most frequently encountered form of the metal, found in not
only fish, but also poultry that have been fed a diet including fishmeal, pesticides, fungicides,
and insecticides (Patrick, 2002). Other forms of Me203Hg+ poisoning that pose a public health
threat are from the adverse effects of thimerosal, a vaccine preservative that is metabolized to
ethylmercury (EtHg) in the body (Aschner and Syversen, 2005).
Mercury toxicity has been recognized as a health threat since the 19th century and is a
serious clinical problem with over 2,000 exposures to mercury or mercury containing
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Figure 1: Atmospheric transport of mercury.
(http://www.mercury.utah.gov/atmospheric_transport.htm)
compounds each year (Watson, 2003). Furthermore, mercury toxicity is considered to be the
second-most common cause of acute heavy metal poisoning (Patrick, 2002). Exposure to
mercury in any form is toxic, but the severity of the response depends upon the route of
absorption in the body and the patient’s response to treatment. Mercury poisoning can result
from digestion, inhalation, injection, or absorption through the skin and is distributed to all body
tissues including the brain. In the body, Me203Hg+ is present as a water-soluble complex, mostly
attached to thiol-containing ligands. Fetuses are particularly vulnerable to Me203Hg+ because of
their rapid brain development. Once ingested it is rapidly distributed to all tissues, causing
toxicity (Koh et al, 2002). The physiological mechanism for removing ingested Me203Hg+ is by
filtration or secretion (Figure 2), the latter requiring basolateral transport of the heavy metal.
While the former process will prevent Me203Hg+ from entering the renal epithelial cells and
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inducing toxicity, the latter (secretion) will promote renal epithelial cell accumulation and
toxicity.

Figure 2: The three exchange processes in the renal tubules. (Principles of Human Physiology,
Third Edition, Figure 18.7, The Urinary System: Renal Function @ 2008 Pearson Education, Inc.
Benjamin Cummings, Co.)
Relatively little is known about the mechanisms involved in the transport of Me203Hg+
by the epithelial cells lining the renal proximal tubule (PT). Previous studies have identified a
divalent metal transporter 1 (DMT1) that is located not only in the gastrointestinal (GI) tract, but
also highly expressed in the kidney. DMT1 transports trace elements, as well as toxic cations
such as Cd²+, Pb²+, Co²+, Ni²+ and Pt²+. Other studies have indicated that Zn²+ may be
transported in the PT complexed to other amino acids such as, L-cysteine or L-histidine via a
sodium-amino acid transporter (Barbier et al, 2005). Toxic metal poisoning may create
competition for these transporters, especially for those heavy metals that form L-cysteine
conjugates such as mercury and cadmium. Heavy metal exposure can cause both acute and
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chronic intoxications with varying levels of severity. The nature of damage that occurs depends
upon the dose, route and duration of exposure (Zalups, 2000). Once mercury is ingested,
elimination from the body must be adequate to prevent toxicity.
Current clinical strategies for removing Me203Hg+ include hemodialysis, chelation
therapy (a type of treatment that uses ethylenediaminetetraacetic acid [EDTA] to bind mercury
and clear it from the body), and exchange transfusion (Koh et al, 2002). Heavy metals such as,
mercury, have a high affinity and bind readily with free sulfhydryl groups (Aschner and
Syversen, 2005). The sulfhydryl-containing anionic compound dimercaptopropanesulfonate
(DMPS) has been successfully used as a chelation agent in mercury toxicity and is itself excreted
in the urine in high concentrations, but the pathway for this remains unknown (Koh et al, 2002).
Furthermore, the mechanisms of Me203Hg+ uptake, accumulation and excretion all along the
nephron remain largely unknown. Therefore, the current study will focus on the transport of
Me203Hg+ by the kidney.
To fully understand the mechanism of transport of Me203Hg+ by the kidney it is first
necessary to describe the functional anatomy of the kidney and elucidate to the transport
processes present within the nephron. The kidneys function to both absorb nutrients
(endogenous compounds such as glucose, amino acids and vitamins) from the filtrate and return
them to the blood and also to excrete waste substances (xenobiotics and exogenous toxic
substances) into the lumen for elimination from the body. Secretion of toxic compounds by the
kidney is important in maintaining plasma concentrations and in clearing the body of potentially
harmful products. Divalent cations such as Zn²+, Fe²+ and Cu²+ are essential to homeostasis in
the body. These cations are normally found within the body at very low concentrations that are
tightly regulated as excess or a deficiency in these metals may cause illness or even death
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(Barbier, et al, 2005). Divalent cations of heavy metals such as mercury (Hg), do not however,
have a beneficial significance in the human body.
The kidney consists of two distinct regions, both an outer cortex and an inner medulla
(Figure 3). Within the cortex and medullary regions, is the functional unit of the kidney known
as the nephron (Figure 3). Humans contain approximately 0.8 X 106 to 1.2 X 106 nephrons,
which consist of the renal corpuscle and the tubule segments. The renal corpuscle contains the
glomerular capillaries and Bowman’s capsule. The glomerulus produces a protein-free
ultrafiltrate from the plasma.

Figure 3: Macroscopic anatomy of the kidney (Principles of Human Physiology, Third Edition,
Figure 18.2, The Urinary System: Renal Function @ 2008 Pearson Education, Inc. Benjamin
Cummings, Co.)
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The tubule consists of: (1) the PT, (2) the loop of Henle including the descending thin
limb, ascending thin limb and ascending thick limb, (3) the distal convoluted tubule, and (4) the
collecting duct (Figure 4). The fluid entering the tubular portion of the nephron absorbs the
remaining endogenous substances and ultimately forms urine.
Within the kidney, two types of nephrons can be distinguished: superficial (or cortical)
and juxtamedullary based on the length of the loop of Henle and the position of the glomerulus
in the cortex (Figure 5).

Figure 4: Anatomy of the nephron (Principles of Human Physiology, Third Edition, Figure 18.3,
The Urinary System: Renal Function @ 2008 Pearson Education, Inc. Benjamin Cummings,
Co.)
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Superficial nephrons generally have short loops of Henle with midcortical glomeruli, while
juxtamedullary nephrons generally have longer loops of Henle and are located in the
corticomedullary boundary. Humans have approximately 80-85% superficial nephrons and 1520% juxtamedullary nephrons.
The PT begins at the glomerulus and consists of an initial convoluted portion, the pars
convoluta, which is a continuation of the parietal epithelium of Bowman’s capsule and continues
on to a straight segment, the pars recta (Figure 4). The length of the PT in humans is
approximately 14 mm and in the rabbit, the length is about 10 mm. Three distinct segments

Figure 5: Locations of cortical and juxtamedullary nephron (Principles of Human Physiology,
Third Edition, Figure 18.4, The Urinary System: Renal Function @ 2008 Pearson Education, Inc.
Benjamin Cummings, Co.)
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of the PT can be distinguished, S1, S2, and S3 based upon their histology. The initial portion of
the proximal tubule, the S1 segment begins at the glomerulus and constitutes approximately two
thirds of the pars convoluta. The S2 segment consists of the remainder of the pars convoluta and
the initial portion of the pars recta. The S3 segment represents the remainder of the pars recta and
is located in the deep inner cortex and the outer stripe of the outer medulla.
The morphology of the PT epithelial cells exhibit polarity of structure and function which
aid in the transport and absorption of many substances, such as Na+, HCO3-, Cl-, K+, Ca2+, PO43-,
water, and organic solutes such as glucose and amino acids from the blood into the lumen of the
cell. As noted in Figure 6, the epithelial cells of the PT, the basolateral (blood side of the cell)
and the luminal or apical membrane (urine side of the cell) begin and end at the tight junctions,
which segregate the transport proteins of the basolateral and luminal membranes thereby
coordinating paracellular transport movement. However, the tight junctions found in the PT are
quite leaky making them permeable to water and most ions, which is in direct contrast to the
tight junctions located in the distal tubules and collecting ducts. The basolateral plasma
membrane forms numerous lateral invaginations and lateral cell processes which extend from the
apical to the basal surface. These lateral cell processes and invaginations also serve to increase
the intercellular space of the basolateral membrane which is also where the Na+,K+ATPase or
Na+ pump is located. Housed within the lateral cell processes elongated mitochondria can be
found and are in close proximity to the plasma membrane, which is characteristic of active
transport mechanisms. The apical or luminal surface of the PT, contains extensive microvilli
forming the brush border membrane and thereby greatly increasing the surface area of apical
membrane. The polarity of the PT epithelium is further evidenced by the unequal distribution of
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enzymes, receptors and membrane-bound transporters between the apical and basolateral
membranes.
As previously mentioned, the PT has three morphologically distinct segments, S1, S2, and
S3. The S1 segment has a tall brush border and a well-defined vacuolar-lysosomal system. The
plasma membrane on the basolateral side of the S1 segment has numerous lateral invaginations
and lateral cell processes containing mitochondria, which is indicative of many active transport
processes. The S2 segment is quite similar to that of the S1 segment; however, the brush border
is shorter, fewer basolateral invaginations are found, and mitochondria are smaller. Within the
S3 segment, virtually no lateral cell processes or invaginations are noted and very few, small
mitochondria are randomly distributed within the cell.

Figure 6: Epithelial cells in selected portions of a renal tubule (Principles of Human Physiology,
Third Edition, Figure 18.17a, The Urinary System: Renal Function @ 2008 Pearson Education,
Inc. Benjamin Cummings, Co.)
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As aforementioned, the proximal tubule is responsible for the uptake of amino acids
which occur via several amino acid transporters both on the luminal and basolateral membranes.
These amino acid transporters may be ion dependent (e.g., Na+), or utilize a H+ gradient and are
mostly located on the luminal membrane within the pars convoluta of the proximal tubule to
facilitate absorption of amino acids from the filtrate. Furthermore, these transport systems are
classified based upon their ability to transport neutral, acidic or basic amino acids. On the
luminal membrane, system B0,+ has been shown to transport neutral and dibasic amino acids and
previous studies have shown that methylmercury thiol-conjugates were transported from lumento-cell by system B0,+ (Bridges and Zalups, 2006). The basolateral membrane contains at least
two amino acid transporters, A and ASC, which are responsible for the uptake of Na+-dependent
or neutral amino acids. Cysteine or homologs of L-cysteine with an additional carbon would be
candidates for these amino acid transport systems on the basolateral membrane.
The epithelial cells lining the renal PT have been shown to be the primary cellular targets
where mercuric ions gain entry, accumulate, and induce toxic effects in vivo (Zalups and
Barfuss, 1993). Previous studies with other divalent cations, such as Zn²+, have implicated that
these metals may be transported in the kidney bound to amino acids using a Na+-dependent cotransporter (Barbier et al, 2005). Other studies have implicated at least one of the organic anion
transport systems as the method of mercury uptake in the kidney (Koh et al, 2002). However,
the mechanism of Me203Hg+ transport, the major form of mercury found in the environment, has
yet to be fully understood. Since free Me203Hg+ is very lipid soluble it is important to examine
the amount of transport that is occurring via simple diffusion in the basolateral membrane versus
actual transport. This will allow for determination of any non-specific binding of Me203Hg+ to
surface membrane proteins. Based on the size of the Me203Hg+ molecule (215 amu) and the
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toxicity it induces in the PT cells, transport in the renal tubule is most likely occurring via
transport with another molecule. Me203Hg+ may be combining with an amino acid to act as a
molecular homolog and be transported along with these amino acids in the proximal membrane.
The most likely candidates for amino acid conjugates are the sulfur containing amino acids such
as, L-cysteine, N-acetylcysteine (NAC), and L-homocstyeine since Me203Hg+ readily forms
bonds with sulfhydryl groups. Furthermore, inorganic mercury is transported as an amino acid
conjugate (e.g., Cys-Hg-Cys) using the organic anion transporter (OAT), which is found in the
basolateral surface of proximal tubule cells (Zalups et al, 2004). However, it is unknown how
the organic form of mercury, Me203Hg+, is transported in the basolateral membrane of the PT.
This current research project using the non-perfused tubule technique, will investigate the
mechanisms for Me203Hg+ transport across the basolateral membrane of the proximal tubule of
the rabbit kidney. Basolateral transport will be examined using non-perfused tubules with a
volume marker ([3H] L-glucose), which will allow for the calculation of the amount of Me203Hg+
that contaminates the sample, measuring the cell-to-bath ratios, cytosolic concentrations, and
tubular contents. Competitive inhibitors of Me203Hg+ conjugates was studied by adding various
amino acids or analogs that are transported by the same amino acid transporters as L-cystine,
such as L-cysteine, N- acetylcysteine (NAC), and L-homocstyeine to the bathing solution.
Molecular characterization of the mechanism of renal transport of Me203Hg+ will enhance our
knowledge of mercury clearance and augment our ability to clinically treat chronic or acute toxic
ingestion of Me203Hg+ by the addition of competitive inhibitors preventing the uptake of
methylmercury in the basolateral membrane of the proximal tubule thus eliminating the
induction of the toxic effects.
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First Hypothesis: Me203Hg+ conjugated to a sulfhydryl-containing amino acid will be
transported across the basolateral membrane into the tubular epithelial cells via an amino acid
transporter. This mechanism of transport will occur via molecular homology or “mimicry” as
the molecular structure of the methylmercury-sulfhydryl conjugate of L-cysteine (Cys-S-MeHgS-Cys) is similar to the amino acid L-cystine (Cys-S-S-Cys).
Second Hypothesis: Me203Hg+ conjugated to sulfhydryl-containing amino acids will be
transported across the basolateral membrane into the tubular epithelial cells by the organic anion
transport (OAT) system.
Third Hypothesis: Me203Hg+ will be bound to a sulfhydryl-containing amino acid when
presented to the basolateral membrane via the blood which will account for the basolateral
membrane uptake of Me203Hg+ in the PT. The rationale for this hypothesis is that the affinity of
Me203Hg+ for sulfhydryl groups is quite high, but the molecular form of Me203Hg+ is presented
for processing in the kidney remains unknown.
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CHAPTER II: REVIEW OF THE LITERATURE

Methylmercury’s history and toxicity
Methylmercury is just one of the many forms of the heavy metal, mercury (Hg). Mercury
has been around for many years and in fact dates back in history to 1100 BC when the Chinese
first mined a compound called cinnabar, vermillion, or Chinese red which was in fact mercury
sulfide. Some argue that humans have been exposed to the methylated form of the metal dating
back to before Homo sapiens evolved (Clarkson, 2002). Around 1500 BC, mercury was also
found in Egyptian tombs. During the 1800s, mercury was used in hat making by the felters,
who were subject to chronic exposures, giving rise to the term “mad as a hatter” as they appeared
insane. Methylmercury first appeared during the 1860s when it was synthesized in a laboratory
in London and subsequently killed two of the laboratory technicians.
The cycling of mercury begins with the evaporation of mercury vapor from the earth’s
surfaces, particularly volcanoes. Coal plants, fossil fuel combustion, and waste incineration are
also all significant sources of mercury in the environment. Globally, most of the mercury supply
is found in Almaden, Spain which has the largest mercury mine in the world and in Idria,
Slovenia. Mercury has been used in the treatment of burns, chronic skin disorders, leprosy and
syphilis. Dentists have used mercury amalgams since 1833 in New York City (Ozuah, 2000).
Throughout history, mercury was found in a number of medicinal products such as diuretics,
antibacterial agents, antiseptics, and laxatives. The more recent history of mercury includes the
epidemics of Me203Hg+ poisoning that have been documented in Japan and Iraq. The Minamata
Bay, Japan outbreak of the organic form of the metal occurred in 1953 by the release of Hg+
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compounds from a vinyl chloride factory into the bay subsequently poisoning the fish which was
later consumed by the local community. Fifty-two people died in this outbreak, while many
others suffered brain damage, paralysis, and vision impairment. The outbreak in Iraq occurred
from the consumption of homemade bread that was made from seeds treated with ethyl mercury
fungicides (Ozuah, 2000). During this outbreak, the warning labels on the packaging were not in
the native language, so the local community was unaware that the grains were treated with
EthylHg. This was one of the largest outbreaks ever known to occur with over 500 deaths, 6,000
cases admitted to hospitals and as many as, 40,000 individuals poisoned (Clarkson, 2002). The
2006 annual report of the American Association of Poison Control Centers' Toxic Exposure
Surveillance System documented 2,477 exposures to mercury or mercury containing compounds.
Of these, 274 were in children younger than 6 years of age and 961 were in persons older than 19
years. Overall, 23 individuals were reported to have moderate effects, 1 had major effects, and
none died as a result of mercury exposure.
Mercury can exist in three basic forms: elemental mercury, Hg°, liquid or mercury
vapor; inorganic mercury; and organic mercury (ethyl-, methyl-, alkyl-, or phenylmercury). The
toxic effects of the metal depend upon the type of mercury involved, the method of entry, the
exposure dose, and the duration of exposure. The ability of Me203Hg+ to accumulate within the
body results from its binding properties. Therefore, activity of mercury within humans or other
species must consider the different bonding properties of the ions. Mercury ions have a greater
propensity for bonding to sulfur atoms (affinity constants ranging from 1015 – 1020), especially
on thiol-containing molecules, forming –S-Hg-R. Endogenous thiol-containing compounds
include L-glutathione, L-cysteine, L-homocysteine, N-acetylcysteine, metallothionein, and
albumin. Mercury may also bind with oxygen or nitrogen containing compounds, but the affinity
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constants for these groups is about 10 orders of magnitude lower. Although, methylmercury has
a high affinity for sulfhydryl compounds, it may also rapidly redistribute to other sulfhydryl
groups when available, indicating that the complex may be easily dissociated.
Elemental mercury is the pure metallic form of the metal and is most commonly found in
barometers, batteries, calibration instruments, chlor-alki production, dental amalgams,
electroplating, fingerprinting products, fluorescent and mercury lamps, infrared detectors, the
jewelry industry, latex paint, manometers, neon lamps, paper pulp production, photography,
silver and gold production, semiconductor cells, thermometers, and thermostats. Elemental
mercury may also be methylated by microorganisms in soil, water, and the GI tract (Patrick,
2002). The toxic effects of elemental mercury transpire after the metal becomes oxidized to the
mercuric ion (Hg2+) which may then inhibit cellular function by acting as an enzyme inhibitor, a
protein denaturant, may interfere with membrane transport, and neurotransmitter release and
uptake. Acute exposure to elemental mercury in significant quantities may produce damage to
the lungs, skin, eyes, and gingival (turns green). Lower dose chronic exposures involve the
central and peripheral nervous systems (Ozuah, 2000). Manifestations of chronic exposure
commonly include excitability, irritability, tremors and gingivitis (Patrick, 2002).
Inorganic mercury (Hg2+), or mercury salts, consists of elemental mercury bound to any
other atom except carbon and is formed from the metabolism of elemental mercury vapor or
methylmercury. Inorganic mercury is found in antiseptics, antisyphilitic agents, acetaldehyde
production, chemical laboratory work, cosmetics, disinfectants, diuretics, explosives, embalming
fluid, fur hat processing materials, ink manufacturing, laxatives, mercury vapor lamps, mirror
silvering, perfume processing, photography materials, spermicidal jellies, tattooing inks,
taxidermy production, teething powders, vinyl chloride production, and wood preservation.
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Within the body, inorganic mercury will complex with glutathione in the liver and be secreted in
bile as a cysteine-mercury or glutathione-mercury complex (Patrick, 2002). Acute inorganic
mercury toxicity primarily affects the kidneys and GI tract. Chronic exposure primarily affects
the kidney possibly causing renal failure and the GI tract manifesting as colitis, stomatitis,
gingivitis, and extreme salivation (Patrick, 2002).
Organic mercury consists of a mercury atom bonded to at least one carbon, and primarily
consists of methylmercury (CH3HgX) and phenyl mercury (C6H5HgX). The organic form of the
metal is also the most toxic and frequently encountered form of exposure. Organic mercury
toxicity may result from exposure to antiseptics, bactericidals, embalming agents, the farming
industry, fungicides, germicidal agents, insecticidal products, laundry products, diaper products,
paper manufacturing, pathology products, histology products, seed preservation, and vaccine and
wood preservatives. Acute exposure to MeHg+ involves the central nervous system,
cardiovascular disease, and the kidney. Nearly all of the MeHg+ (~ 95 %) ingested will be
absorbed in the GI tract, although where is still unknown, and subsequently distributed to body
tissues (Clarkson, 2002). The remaining 5 % will be found in the blood, mostly bound to red
blood cells, but some still remains in the plasma. The half-life of MeHg+ in the body is quite
long, approximating 70 days.
In patients suspected of mercury poisoning, it is important to review the patient’s
occupation, hobbies and consumption of seafood in order to determine the level of exposure.
However, both acute and chronic toxicity involve multiple organ systems leading to further
diagnostic complications and may even be suggestive of other diseases. Mercury poisoning may
present in many ways depending on the form of mercury involved. Elemental mercury usually
results in acute toxicity and can lead to pulmonary distress. Symptoms such as shortness of
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breath, fever, chills, chest pain, metallic taste, lethargy, confusion, and vomiting may occur.
Exposures to inorganic mercury mainly occur through the oral cavity and GI tract with initial
symptoms of vomiting, severe abdominal pain, shock, and discoloration of the mucous
membranes. Within hours of exposure symptoms may escalate to include loosening of the teeth,
metallic taste, and inflammation of the mucosal membranes in the mouth, gingivitis, and necrosis
of the renal tubules. Chronic exposures most often result from the organic form of the metal via
ingestion of contaminated food, but may also involve acute exposures. The onset of symptoms
are usually delayed for days to weeks following exposure and will manifest as neurological,
hearing loss, mental deterioration, muscle tremors, paralysis, and possibly death. Thus, a better
understanding of MeHg+ transport in the kidney will enhance our ability to clinically treat
patients exposed to this toxic substance (by facilitating excretion) and preventing entry into the
epithelial cells of the kidney.

Methylmercury’s induced nephrotoxicity
The kidneys are the primary organs where all forms of mercury are absorbed,
accumulated, and will ultimately express toxicity (Zalups, 2000). As aforementioned, the extent
of renal damage will depend upon the nature of exposure. Heavy metal uptake in the kidneys
can occur via different pathways depending upon the form of the element and segment of the
nephron where absorption occurs. Divalent cations in the body may exist as either a nondiffusible (bound to a protein) or diffusible (ionized) form. Heavy metal ions in the blood bind
rapidly to albumin, the most abundant protein in the plasma. However, the albumin-metal
conjugate formed will not be present in the ultrafiltrate of the nephron as the size of the molecule
is too large to pass through the glomerular filtration membrane. Since the majority of mercury
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does not exist in the free ionic form in blood, but rather bound to some protein, identification of
the mercury conjugate will give further insight into how this metal enters the epithelial cells via
the basolateral and luminal membrane of the kidney and induces its toxic effects.
Both the inorganic and organic forms of the heavy metal have been shown to
accumulate primarily in the renal cortex and the outer stripe of the medullary region (Zalups,
2000). In a review by Zalups, it was noted that studies have shown that the predominant form of
mercury within the kidney of animals exposed to MeHg+ is of the inorganic form, suggesting that
MeHg+ is oxidized to inorganic mercury before or after entering the renal tubule epithelial cells
but the mechanism for this transformation remains unknown (Zalups, 2000). Although the renal
disposition of divalent cations, such as MeHg+ have not been fully elucidated, research studies
indicate that the proximal tubule is the primary site of absorption with nearly 70% of the
transport occurring within this segment of the nephron (Barbier, 2005). When considering the
nephrotoxicity of MeHg+, the excretion of the heavy metal must also be considered. Several
pathways have been described for the elimination of the metal from the body, including
acetylation and conjugation with L-cysteine and L-glutathione by the liver. Most (~90%) of the
MeHg+ will exist via fecal excretion, leaving only a small portion of MeHg+ to exit via the urine
after acetylation in the liver (Ozuah, 2000). The N-acetyl-homocysteine methylmercury
complex will be excreted along with bile for presentation at the kidneys. This complex may then
be absorbed within the renal tubules allowing for the toxic effects of the metal to be induced.
However, the location and mechanism of uptake have not been elucidated to date.
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Transport of methylmercury across the basolateral membrane in the proximal tubule
The proximal tubule functions as a major transport site for solutes within the nephron,
both on the basolateral (blood) and apical (urine of filtrate) membranes. A previous study by
Zalups and Barfuss in 1993 examined the luminal transport and toxicity of unbound Me203Hg+ in
the isolated perfused tubule of the rabbit kidney and noted that the S1 segment of the proximal
tubule was most vulnerable to the toxic effects of free MeHg+ as seen by the extent of cellular
injury and degeneration that occurred during perfusion with free Me203Hg+ at very low
concentrations. This study also demonstrated that free or unbound inorganic mercury (Hg2+)
does not appear to produce the same level of toxicity to the proximal tubule. Other research has
shown that the luminal uptake of inorganic and to some extent, organic mercury within the
kidney is linked to the activity of γ-glutamyltransferase (γ-GT), an enzyme predominantly found
in the luminal membrane of the proximal tubule (Zalups, 2000).
The proximal tubular cells contain two major organic transport mechanisms, the organic
anion transporter (OAT) and the organic cation transporter (OCT) and amino acids transport
systems. The organic anion transporter is located on both the basolateral (OAT1, OAT2, OAT3)
and luminal (OAT4) side of the PT and functions to carry anions across the membrane. Several
molecular species of organic anion transport have been cloned, two of which (OAT1and OAT3)
are expressed in the basolateral membrane of the proximal tubule. OAT1 is predominantly
found in the S2 segment of the proximal tubule, and to a lesser extent it is also found in the S1
and S3 segments and OAT3 is expressed in all segments of PT (S1 > S2 = S3). Evidence
implicating the basolateral uptake of mercuric ions via the organic anion transporter comes from
studies showing pre-treatment with para-aminohippurate (PAH), a competitive substrate for
OAT, caused significant reductions in the transport of inorganic mercury (Zalups, 2000). Other
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data have also shown that probenicid, another specific substrate for OAT, significantly reduced
the renal uptake and accumulation of organic mercury compounds on the basolateral membrane
of the proximal tubule (Zalups, 2000).
The organic anion transporters (OATS) within the proximal tubule are driven by a
dicarboxylate gradient which is produced by a dicarboxylic acid exchanger mechanism at the
basolateral membrane and via intracellular metabolism. Normal metabolic processes with the
renal epithelial cells generate α-ketoglutarate, resulting in a gradient favoring the movement of
this compound out of the cell. If the gradient becomes large enough, α-ketoglutarate is
exchanged with organic anions via OAT. Furthermore, α-ketoglutarate along with other
dicarboxylic acids, may all re-enter via the basolateral membrane by the Na+-dicarboxylic acid
cotransporter driven by the Na+ or sodium ion gradient, which is produced by the Na+, K+ATPase mechanism. It is plausible to then ascertain that other dicarboxylates may create
competition for the sodium dependent uptake of α-ketoglutarate at the dicarboxylic acid
cotransporter thereby reducing the basolateral mechanism promoting the update of αketoglutarate. This will in turn, decrease the concentration of α-ketoglutarate and further reduce
its movement out of the proximal tubular cells in exchange for the uptake of an organic anion.
Furthermore, excessive dicarboxylates may also present competition for organic anion transport
at OAT and hence, decrease mercuric conjugates presented at the basolateral membrane as well.
Other studies have suggested that conjugated Hg2+ is taken up by the proximal tubule cells of the
kidney via an organic anion exchanger, but the mechanism of this transporter has not been well
characterized (Zalups et al, 2004).
Several possible ligands have been suggested to be bound to mercury when presented at
the organic anion transporter of the basolateral membrane of the proximal tubule. Two ligands
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that have been examined are L-glutathione and L-cysteine. Glutathione transport by OAT was
demonstrated by studies of Lash and Jones in 1983, who showed that transport of this tri- amino
acid, was blocked by probenicid. Other data has demonstrated that L-cysteine conjugates were
also OAT dependent and transport was inhibited by PAH and probenicid. These data implicate
that mercuric conjugates of L-glutathione and L-cysteine, as well as, any other thiol containing
amino acid or amino acid derivative such as DL-homocysteine, N-acetylcysteine, L-taurine or Lmethionine could also be taken up at the basolateral membrane of the proximal tubule by the
organic anion transport system.
The organic cation transporters (OCT) are also located on the basolateral (OCT1, OCT2,
OCT3) and luminal (OCT2) membrane and transport cations, as well as, weak organic bases.
Two transporters have been identified known as OCT1 and OCT2. This class of compounds
includes molecules that are not only physiologically important, but may also include molecules
that have a toxicological effect in the body. Organic cation entry into the cell via the basolateral
membrane occurs because of the inside negative membrane potential, whereas organic cation
exit follows a transmembrane electrochemical gradient for H+. In the kidney, the proximal
tubule is the primary site of active organic cation secretion (Wright, 2004).
As previously stated, very little is known about the transport of MeHg+ in the proximal
tubule. Other heavy metals, such as zinc, have been shown to be transported attached to an
amino acid via a sodium ion or Na+-dependent amino acid exchanger, therefore; maybe MeHg+
is conjugated to an amino acid in the same way during transport. Previous studies have
established that the proximal tubule contains amino acid transport systems present in both the
basolateral and the luminal membranes (Cannon et al, 2001; Kanai and Endou, 2003). Luminal
transport studies of Me203Hg+ were done in 1993 by Barfuss and Zalups which demonstrated
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differential toxicity of Me203Hg+ among the three segments of the proximal tubule. That study
found that the S1 segment of the proximal tubule was most vulnerable to the toxic effects of
Me203Hg+ as seen by the extent of cellular injury and degeneration that occurred during perfusion
with Me203Hg+ at very low concentrations of free Me203Hg+ and that free inorganic mercury
(Hg2+) does not appear to produce the same level of toxicity to the proximal tubule. However,
the transport of MeHg+ has yet to be fully characterized for the luminal or the basolateral
membranes of the proximal tubule. A better understanding of the renal mechanisms of MeHg+
transport within the body and ultimately blocking those transport mechanisms thereby allowing
the metal to be excreted in the urine will enhance the clinical treatment of mercury poisoning.
This is the first study designed to address the transport of MeHg+ at the basolateral membrane.

Possible measures that protect against Me203Hg+ toxicity
Accelerating MeHg+ clearance from the body can reduce or eliminate its toxicity.
However, the mechanisms of MeHg+ clearance from the body remains unknown. As mentioned
above, divalent cation transporters (DCT) in the proximal convoluted tubule cells of the kidney
are important for the regulation of plasma concentrations of endogenous and exogenous
compounds including those that are toxic. One of the current mechanisms of accelerating
MeHg+ clearance involves the use of chelating agents. The more commonly used chelators
consist of non-sulfur conjugates such as, ethylenediaminetetraacetate, triethylenetetramine,
deferoxamine, and deferiprone or sulfur containing compounds such as, meso-2,3dimercaptosuccinic acid (DMSA), DMPS, and diethyldithiocarbonate, both of which can be
toxic to the human body. The sulfur containing chelators make use of the bonding properties of
MeHg+, encouraging the metal to move from one sulfhydryl-containing compound to another.
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Another chelating agent, N-acetylcysteine, which is not toxic to the body and rapidly eliminated
in the urine has been investigated as a possible use in the treatment of MeHg+ poisoning
(Ballatori et al, 1998). These chelating agents could be used to treat acute and chronic
exposures to methylmercury by facilitating the secretion of the metal into the urine and
ultimately out of the body
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CHAPTER III: MATERIALS AND METHODS

Animals
Female New Zealand White rabbits (1-2 kg) were used in the current study. Rabbits were
adapted to housing for at least two days prior to any experimentation. Water and a commercial
laboratory diet for rabbits were provided ad libitum during all phases of the study.

Composition of buffer solution
The buffer solution for all experiments consisted of a simple electrolyte solution. Tissue
was placed in a sucrose/phosphate buffer containing 125 mM sucrose, 13.3 mM anhydrous
monosodium dihydrogen phosphate (NaH2PO4), and 56 mM anhydrous disodium monohydrogen
phosphate (Na2HPO4). The pH was adjusted to 7.4 by the addition of either 1 N NaOH (sodium
hydroxide) or HCl (hydrochloric acid). The osmolality was adjusted to 290 mOsm/Kg of water
by the addition of either water or NaCl (sodium chloride).

Composition of bathing and tubular dissection solution
In all experiments performed the solution used for tubular dissection and bathing of the
non-perfused tubules consisted of 140 mM Na+, 140 mM Cl-, 5 mM K+, 2.5 mM Ca2+, 1.2 mM
Mg2+, 1.2 mM SO42-, 2 mM HPO42-/H2PO4-, 1 mM D-glucose, and 0.5 mM L-glutamate. The pH
was adjusted to 7.4 by the addition of either 1 N NaOH or HCl. The osmolality was adjusted to
290 mOsm/Kg of water by the addition of either water or NaCl. To evaluate the transport of
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Me203Hg+ or conjugates thereof, Me203Hg+ was added to the bathing solution. [3H]-L-glucose
(14.6 Ci/mmol; American Radiolabeled) was added to the bathing solution as a volume marker.
[3H]-L-glucose is used as a volume marker because it does not adhere to cell membrane, is not
transported, is only slightly able to penetrate tight junctions or cell membranes and is water
soluble.

Preparation of 203Hg+
The preparation of 203Hg+ begins with 3 mg of pure HgO (mercury oxide) sealed in a
pure quartz (silicone oxide) ampule which is heated to seal closed. The sealed ampule is sent to
the University of Missouri Research Reactor Center (MURR) in Columbia, Missouri to be
irradiated. During irradiation, the 3 mg of HgO becomes 203HgO. The 3 mg of 203HgO is
converted to 203HgCl2 by crushing the ampule in a 2 ml plastic vial and adding 1 ml of 1 N HCl.
This process occurs within a radioactive hood, behind a lead shield with lead bricks protecting
both the right and left sides and using all necessary radiation safety precautions. This solution is
allowed to incubate for approximately 24 hours to complete the conversion of 203HgO to
203

HgCl2. Following incubation, the solution is separated from the crushed quartz by transferring

to a new vial and the specific activity is measured using an Ion Chamber (1mCi=0.52mR/hr at
0.5M (19.6”) or 1mCi=0.16mR/hr at 1.0M (39.36”)).

Preparation of Me203Hg+
The method used for preparation of Me203Hg+ was adapted from Rouleau and Block. A
2 M acetate buffer solution was prepared by adding 11.8 ml of glacial acetic acid to 50 ml of
Millipore water (de-ionized tap water that has been further filtered using the Millipore filter
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system) in a 125 ml FEP (a specific polymer of plastic that minimizes binding) bottle. Then 27.2
g sodium acetate was added and the solution was diluted to 100 ml. This acetate buffer solution
was stored in the freezer between experiments. Next, 25 mg of methylcobalamin (the methyl
donor) was dissolved in 12 ml of the acetate buffer which turned the solution red. This solution
was also stored in the freezer between experiments. The final solution was a 30% KCl in 4%
HCl which was prepared by dissolving 37.5 g of potassium chloride in 100 ml of Millipore water
in a 125 ml FEP bottle and then adding 5 ml of HCl diluted to 125 ml. Heat was added to the
solution to facilitate dissolving and then stored at room temperature between experiments. The
203

HgCl2 was prepared by adding 203Hg from the original recovery stock solution in 1N HCl with

a minimum volume of 40 µl to 1 ml of Millipore water. This solution was then placed in a dried
trace metal acid washed 20 ml glass scintillation vial. The pH of this solution was measured to
ensure a range of 1-2 which is crucial because if the pH is too high the conversion efficiency to
Me203Hg+ will be compromised. Alternatively, if the pH is too low, dimethyl-Hg will be formed
instead of Me203Hg+.
The reaction solution was then prepared by adding 0.67 ml of the 2M acetate buffer
solution to the 20 ml scintillation vial containing the 1 ml dilute 203Hg. Next, 2 ml of the
methylcobalamin solution was added and then placed in the lead pig to react for approximately
24 hours. The final volume of the reaction solution was 3.67 ml. The total activity was
measured using an Ion Chamber (1mCi=0.52mR/hr at 0.5M (19.6”) or 1mCi=0.16mR/hr at 1.0M
(39.36”)).
The extraction of the Me203Hg+ was performed by adding 16.7 ml of the potassium
chloride solution, 16.7 ml Millipore water and the 3.67 ml reaction mixture to a 125 ml Nalgene
separatory funnel (giving a total volume of 37.07). The Me203Hg+ was then extracted with five
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washes of 8.3 ml of dichloromethane (DCM). The sequence of washes to extract the Me203Hg+
was as follows. The pipet was first conditioned by flushing with DCM to prevent dripping.
After each addition of 8.3 ml DCM to the solution in the funnel, the separation funnel cap was
tightened and then inverted several times to facilitate mixing. Following mixing, the solution
was vented by unscrewing the top of the funnel and then the cap was re-tightened. The separator
funnel was then place in a foil covered beaker on a benchtop shaker set at approximately 10 rpm
and mixed gently for 5 minutes keeping the funnel covered with foil to prevent any light from
entering. Following mixing, the funnel was then secured to a stand, the funnel cap was opened
and a clean FEP (250 ml) bottle that was wrapped in foil was placed beneath with the valve
open. The DCM was then drained from the bottom layer into the FEP bottle. The extraction
washes were repeated five times giving a final volume of 41.5 ml of the DCM- Me203Hg+
solution. The waste solution (red) was drained out of the funnel into the 125 ml FEP bottle.
Next, the DCM- Me203Hg+ solution was poured back into the separation funnel and washed twice
with 8.3 ml of Millipore water. The top, clear, pink layer formed the aqueous layer and the
bottom, clear, colorless layer contained the Me203Hg+ in DCM which was saved into the same
250 ml FEP and stored behind the lead shields. The aqueous layer was drained into the waste
bottle containing the red solution.
The final extraction of Me203Hg+ was performed by adding 8.3 ml of Millipore water to
the DCM layer. Nitrogen (N2) gas was then bubbled through the water layer into the DCMMe203Hg+ solution by using a hypodermic needle on one end of the tubing. The N2 gas was
released at about 5 bubbles per second to ensure that freezing of the solution did not occur. This
final extraction step occurred in the dark, covering the FEP bottle aluminum foil and shielded
with lead. All of the DCM solution was allowed to evaporate until only 8.3 ml of the water
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remained containing the Me203Hg+. This final solution was placed in a pre-weighed trace metal
acid washed glass 20 ml scintillation vial and weighed to determine the final volume. Pure HCl
was added resulting in a final 8.3 ml of Me203Hg+ solution in 1% HCl by volume.
Samples of 20 µM Me203Hg+ and 5 µM [3H]-L-Glucose were dried down to remove the
HCl solution. Dried samples were then reconstituted in the standard bathing solution using
various amino acids or amino acids plus inhibitors for individual experiments.

Procedure for obtaining segments of proximal tubules
Rabbits were anesthetized with a combination of 33 mg/kg ketamine (FORT DODGE)
and 33 mg/kg xylazine (LLOYD). When the rabbit reached a state of deep anesthesia
(determined by the absence of a corneal reflex) the abdominal wall was cut and the kidneys were
immediately removed. The kidneys were then immediately sliced into 1-2mm thick coronal
sections using a single-edge razor blade and placed in a cold (4°C) aqueous sucrose-phosphate
buffer solution on ice to be stored for up to 8 hours for dissection. Individual tubule segments
were obtained by manual dissection while in the dissection solution. The S1, S2 and S3 segments
of the proximal convoluted tubule (PCT) were individually dissected from the coronal sections.
The S1 segments were identified as convoluted tubules dissected from the outer cortical region of
the kidney section. The S2 segments were identified as the straight portion of the proximal tubule
spanning the entire thickness of the cortex (Figure 7) and the S3 segments were identified as the
terminal 1 mm portion of the proximal tubule located in the outer stripe of the outer medulla.
The S2 were chosen for study because it makes up the major portion of the pars recta of the
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proximal tubule and it not only accumulates the inorganic form of mercury, but is also involved
in the nephrotoxicity induced by inorganic mercury, indicating these same effects may be
involved with the transport of Me203Hg+.

Figure 7: S2 segment of the rabbit proximal tubule.

Method for non-perfused segments of the proximal tubule
Individual dissected tubules were gathered together in the dissection dish by groups of 10-15
tubules. Transfer to the bathing solution occurred by sucking the group of tubules into a glass
pipet via a tuberculin syringe connected by tubing. Dissected tubule segments were then
transferred to a Lucite bathing chamber (Figure 8) connected to either a warm bath (for
experiments performed at 37°C) or a cooling bath (for experiments performed at 12°C). The
Lucite chamber contained 120 µl of bathing solution containing Me203Hg+ alone or Me203Hg+
conjugated to an amino acid, an amino acid derivative, or the conjugate plus an inhibitor.
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Approximately 3 ml of mineral oil was placed on top of the bathing solution to prevent
evaporation of the bathing solution water. The bathing solution was continuously stirred with a
reciprocating piston pump while the tubule segments were incubated for twenty minutes.
Cellular changes were observed during this time for indications of Me203Hg+ toxicity by either
visual conformation of swelling in the tubules or by the use of a vital stain dye [FD&C green
number 3] which will rapidly adhere to cytoplasmic contents, thus indicating that the cellular
membrane has been compromised which is indicative of toxicity to the cells. Individual tubule
segments lengths were measured during the twenty minute incubation period using an ocular
micrometer.

Figure 8: Lucite bathing chamber.
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Harvesting of non-perfused segments of the proximal tubule
After the incubation period, single tubule segments were removed from the bathing
solution via glass pipets that had been manually made using a Microforge to extend the tips of
the pipets. To calculate the cellular content of Me203Hg+ in the non-perfused segments of the
proximal tubule, the tubule was removed from the bathing solution and placed in 10 µl of 3%
(W/V) TCA (trichloroacetic acid). The TCA precipitated the larger proteins leaving the tubule
opaque-white and rigid while releasing the cytosolic contents into the TCA solution. The
reaction is nearly instantaneous so the tubule segment (TCA-precipitable fraction) was removed
after a few seconds of washing from the TCA solution and placed in a vial containing 4 ml of
scintillation fluid. The scintillation vials were later counted using standard isotopic methods for
the contents of 203Hg+ and the volume marker, [3H]-L-glucose. The TCA solution (TCA-soluble
fraction, presumably the cytosolic contents) was also collected, placed in a scintillation vial
containing 4 ml of scintillation fluid and later counted using standard isotopic methods. The
TCA-soluble fraction allowed for the approximate calculation of the cellular content of
Me203Hg+ (µM).

Calculations
In bath-to-cell transport experiments, transport of Me203Hg+ calculations were based on
estimated volumetric cellular concentration taken by the diameter and length of the tubule.
Counts per minute (CPM) were used to determine the concentration of Me203Hg+ or Me203Hg+
conjugates in a given tubule. Pre- and post-bath measurements were counted to estimate any
volume dilution of the bathing solution that may have occurred during tubule transfer. Bath
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concentrations were determined from the isotope concentration (µM) and the pre/post bathing
solution measurements taken.
Cell-to-bath ratio. Cell-to-bath concentration ratio of 203Hg was calculated by dividing
the cytoplasmic concentration (µM) of the tubule by the bathing solution concentration (µM).
Cytosolic concentration. Cytosolic concentration (fmol/mm) of 203Hg was calculated by
multiplying the cytoplasmic concentration (µM) of the tubule by the cell volume (nL) and
dividing by the length (mm) of the tubule segment.
Tubular content. Tubule content (fmol/mm) of 203Hg was calculated by subtracting the
amount of 203Hg (fmol) present in the bathing solution collected along with the tubule
(extracellular 203Hg) from the total tubular 203Hg and dividing by the tubular length. The amount
of extracellular 203Hg was calculated by multiplying the volume of the bathing solution (nl) with
the bathing solution 203Hg concentration (fmol/nl). The volume of the bathing solution collected
with the tubule was measured by multiplying the total tubule 3H-glucose (CPM) by the
concentration of 3H-glucose (nl/CPM) in the bathing solution.

Statistical analysis
A minimum of five tubules were used for each experimental condition. In addition, data
for each parameter was assessed by obtaining tubular segments isolated from at least two
animals. For each non-perfused tubule, the cell-to-bath, cytosolic and tubular concentrations
were averaged. These averaged values were used to compute the overall mean and standard
error for each experimental condition. The mean values of the various groups were tested for
differences using the student’s t-test. Values were assumed to be significantly different when
P<0.05.
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Protocol for plasma samples with Me203Hg+
The initial estimate of the amount of Me203Hg+ bound within the components of the blood
was performed by collecting samples rabbits prior to the removal of the kidneys for the nonperfused experiments described above. Blood was obtained from the renal vein in Na-Citrate
collection vials. Aliquots of 1 ml samples of blood were transferred to micro-centrifuge tubes
(six total) and 5 µl of Me203Hg+ stock solution were added. Three of the six specimens were
vortexed lightly to ensure proper mixing of the solutions. Samples were then centrifuged at
~10,000 RPM for 1-2 minutes to separate the cellular fraction of blood from the plasma. The
three microcentrifuge tubes containing the Me203Hg+ were then placed in a Gamma Counter to
estimate the amount of isotope. Plasma from the remaining three vials was then transferred to
new vials and 5µl of Me203Hg+ was added. These samples were then vortexed lightly and placed
in the Gamma Counter as well. To separate the proteins from the plasma solution, 100 µl of
20% TCA was added and the samples were then centrifuged at ~14,000 RPM for 3-5 minutes.
The plasma was then transferred to new microcentrifuge vials and all vials were placed in the
Gamma Counter for isotopic determination.
Further analysis of the amount of Me203Hg+ bound within the components of the blood
consisted of only examining the plasma fraction. Blood was again obtained from the renal vein
of rabbits in Na-Citrate and Heparin collection vials. Aliquots of 1.5 ml samples of blood were
transferred to micro-centrifuge tubes (six total) and centrifuged at ~10,000 RPM for 1-2 minutes
to separate the cellular fraction of blood from the plasma. Two of the samples (one from the
Heparin collection vial and one from the Na-citrate collection vial) were used as controls. A 100
µl aliquot was removed from each microcentrifuge tube for analysis by mass spectrometry. The
control samples were then mixed with a 20 % TCA solution, centrifuged again at ~10,000 RPM
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for 1-2 minutes to separate the cellular fraction and another 100 µl aliquot was removed from
each microcentrifuge tube for analysis by mass spectrometry.
The remaining four microcentrifuge tubes (two containing the plasma supernatant from
the Heparin collection vial and two containing the plasma supernatant from the Na-Citrate
collection vial) were mixed with a 20 % TCA solution and centrifuged again at ~10,000 RPM for
1-2 minutes to separate the cellular fraction. The supernatant from each of these tubes was then
pipetted into a new microcentrifuge tube and 100 µl of a 20 µM MeHgCl+ solution was added.
These samples were then analyzed by mass spectrometry.

Mass spectrometry
An electrospray-quadrupole/time-of-flight spectrometer (Waters Micromass Q-TOFTM
micro, Waters Corporation, Milford, Massachustts, USA) was used to carry out the mass
spectrometric experiments in a positive or negative mode. The instrument was calibrated with a
sodium formate solution. Nitrogen supplied by a nitrogen generator (Model 75-72, Parker
Balston, Haverhill, MA, USA) was used as the cone gas at 50 L/hr and as the drying gas heated
to 150°C at a flow-rate of 450L/min to evaporate solvents in the spray chamber. Argon was used
as the collision gas. The source temperature was at 80oC and the desolvation temperature was at
150oC. The samples were prepared by mixing with MeOH containing 0.1% HCOOH for
positive mode analysis or MeOH containing 0.5%NH3 for negative mode at a 1:1 ratio. All
solutions were continuously infused by means of a syringe pump at a typical flow-rate of 5 µl
min-1 into the electrospray probe. MassLynx (version 4.0) software was used for instrument
control, data acquisition and processing. Mass spectrometry analysis was performed on
MeHgCl+ and MeHgCl+-amino acid conjugates to identify the binding properties of the molecule
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with the sulfhydryl containing amino acids (L-cysteine, L-methionine, L-taurine, L-glutathione,
DL-homocysteine, N-acetylcysteine). Individual amino acids were examined alone for
confirmation of molecular weight and in combination with MeHg+. Mass spectrometry analysis
was also performed on the supernatant from the plasma samples described above.
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CHAPTER IV: RESULTS

Basolateral transport of Me203Hg+
To characterize the basolateral uptake of Me203Hg+, 20 µM Me203Hg+ was added to the
bathing solution. The average cell-to-bath ratio and cytosolic contents of Me203Hg+ at 12°C and
37°C are noted in Figure 9. Methylmercury uptake (126 ± 13.4) was significantly greater (P =
0.0001) at 37°C when compared to temperature conditions of 12°C (2.5 ± 2.2). The average
cytosolic concentration of Me203Hg+ at 12°C and 37°C are 59 µM ± 51 and 4,360 µM ± 1090.7
(P = 0.0185) demonstrating again increased cellular contents of Me203Hg+ at normal
physiological temperatures. To investigate the amount of Me203Hg+ bound to the basolateral
epithelium the tubular contents (fmol mm -1) and percentage of tubular contents of Me203Hg+ at
12°C and 37°C were examined and are noted in Figure 10. The bound Me203Hg+ at 12°C was
7,418.9 ± 584.5 fmol mm -1 was significantly less than the amount bound at 37°C 20,142.3 ±
2,023.3 fmol mm -1 (P = 0.0005). The percentage of bound Me203Hg+ when compared to the
total contents of Me203Hg+ present in the bathing solution was 99 % and 84 % for 12°C and 37°C
(P = 0.01), respectively.
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Figure 9: Me203Hg+ transport in the basolateral membrane of the S2 segments of rabbit proximal
tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each value represents the mean ±
SE with a minimum sample size of 5 tubules. The “*” indicates a significant statistical
difference, P≤0.05.
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Figure 10: Me203Hg+ transport in the basolateral membrane of the S2 segments of rabbit proximal
tubules (A) tubular contents and (B) tubular content expressed as percentage of total extracted.
Each value represents the mean ± SE with a minimum sample size of 5 tubules. The “*”
indicates a significant statistical difference, P≤0.05.
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The effect of TEA on basolateral transport of Me203Hg+
To characterize the effect of TEA on the basolateral uptake of Me203Hg+, 20 µM
Me203Hg+ along with 22 µM TEA was added to the bathing solution. The average cell-to-bath
ratio and cytosolic contents of Me203Hg+-TEA at 37°C are noted in Figure 11. Bath-to-cell
uptake of Me203Hg+-TEA (162.5 ± 34) was not significantly increased (P = 0.2380) at 37°C
when compared to uptake of Me203Hg+ alone (126 ± 13.4). The average cytosolic concentration
of Me203Hg+ and Me203Hg+-TEA are 4,360 µM ± 1090.7 and 2,282.5 µM ± 500 (P = 0.202)
demonstrating no significant increase in the cellular contents of Me203Hg+ versus Me203Hg+-TEA
at normal physiological temperatures. The amount of Me203Hg+ versus Me203Hg+-TEA bound to
the basolateral epithelium the tubular contents (fmol mm -1) and percentage of tubular contents
are noted in Figure 12. The bound Me203Hg+-TEA complex (22,388 ± 2,820.5 fmol mm -1) was
not significantly greater than the bound Me203Hg+ (20,142.3 ± 2,023.3 fmol mm -1) (P = 0.525).
The percentage of bound Me203Hg+-TEA complex compared to the percentage of Me203Hg+
bound was 92.1 % and 84 % (P = 0.097), respectively.
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Figure 11: The effect of TEA on Me203Hg+ transport in the basolateral membrane of the S2
segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each
value represents the mean ± SE with a minimum sample size of 5 tubules.
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Figure 12: The effect of TEA on Me203Hg+ transport in the basolateral membrane of the S2
segments of rabbit proximal tubules (A) tubular contents and (B) tubular content expressed as
percentage of total extracted. Each value represents the mean ± SE with a minimum sample size
of 5 tubules.
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The effect of L-cysteine on the basolateral transport of Me203Hg+
To characterize the effect of L-cysteine on the basolateral uptake of Me203Hg+, 20 µM of
Me203Hg+ along with 22 µM of L-cysteine was added to the bathing solution. The average cellto-bath ratio and cytosolic contents of Me203Hg+-L-cysteine at 12°C and 37°C are noted in Figure
13. Bath-to-cell uptake of Me203Hg+-L-cysteine (32.1 ± 5.2) was significantly increased (P =
0.0023) at 37°C when compared to uptake of Me203Hg+-L-cysteine at 12°C (7.3 ± 2.3). The
average cytosolic concentration of Me203Hg+-L-cysteine at 12°C and 37°C was 119.2 µM ± 37
and 496.8 µM ± 71.2 respectively, demonstrating significantly (P = 0.001) increased cellular
contents of Me203Hg+-L-cysteine at normal physiological temperatures. The amount of
Me203Hg+-L-cysteine at 12°C and 37°C bound to the basolateral epithelium of the tubule (fmol
mm -1) and percentage of tubular contents are noted in Figure 14. The amount of bound
Me203Hg+-L-cysteine complex at 37°C was 11,107.8 ± 1,822.6 fmol mm -1 which is significantly
(P = 0.0008) greater than the bound Me203Hg+-L-cysteine at 12°C was 1,533.4 ± 233.9 fmol mm 1

. The percentage of bound Me203Hg+-L-cysteine complex at 12°C compared to the percentage

of Me203Hg+-L-cysteine bound at 37°C was 93.5 % and 89.6 % (P = 0.3120), respectively.
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Figure 13: Me203Hg+-L-cysteine transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each value
represents the mean ± SE with a minimum sample size of 5 tubules. The “*” indicates a
significant statistical difference, P≤0.05.
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Figure 14: Me203Hg+-L-cysteine transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) tubular contents and (B) tubular content expressed as percentage of
total extracted. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
The “*” indicates a significant statistical difference, P≤0.05.
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The effect of PAH on the basolateral transport of Me203Hg+-L-cysteine
To determine if the conjugate, Me203Hg+-L-cysteine, is being carried through one of the
OAT transporters 200 µM of PAH was added to the bathing solution along with 20 µM of
Me203Hg+ and 22 µM of L-cysteine. The average cell-to-bath ratio and cytosolic contents of
Me203Hg+-L-cysteine versus Me203Hg+-L-cysteine+PAH is shown in Figure 15. The addition of
PAH to the bathing solution significantly reduced the amount of Me203Hg+-L-cysteine being
transported from the bath-to-cell (9.2 ± 2.6, P = 0.0053) and the amount of cytosolic contents
within the cell (162.6 µM ± 46.6, P = 0.0067). Figure 16 shows the amount of bound Me203Hg+L-cysteine at the tubular epithelium was significantly increased in the presence of PAH,
(29,262.2 fmol mm -1 ± 2,501.3, P = 0.0001). This also represented a statistically significant
increase in the overall percentage of bound tubular contents of Me203Hg+-L-cysteine in the
presence of PAH, (99.3 %, P = 0.018).
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Figure 15: The effect of PAH on Me203Hg+-L-cysteine transport in the basolateral membrane of
the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM.
Each value represents the mean ± SE with a minimum sample size of 5 tubules. The “*”
indicates a significant statistical difference, P≤0.05.
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Figure 16: The effect of PAH on Me203Hg+-L-cysteine transport in the basolateral membrane of
the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular content
expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of probenicid on the basolateral transport of Me203Hg+-L-cysteine
Further classification of whether the conjugate, Me203Hg+-L-cysteine, is being carried
through one of the OAT transporters was determined by the addition of 200 µM probenicid to
the bathing solution along with 20 µM of Me203Hg+ and 22 µM of L-cysteine. The average cellto-bath ratio and cytosolic contents of Me203Hg+-L-cysteine versus Me203Hg+-Lcysteine+probenicid is shown in Figure 17. The addition of probenicid to the bathing solution
reduced the amount of Me203Hg+-L-cysteine being transported from the bath-to-cell (16.8 ± 3.4)
although the results were not statistically significant (P = 0.1545). The amount of cytosolic
contents within the cell were also reduced in the presence of probenicid (310.2 µM ± 62), but
were also not statistically significant (P = 0.2122). Figure 18 shows the amount of bound
Me203Hg+-L-cysteine at the tubular epithelium was significantly increased in the presence of
probenicid (21,107 fmol mm -1 ± 3,152.1, P = 0.0181). This did not represent a statistically
significant increase in the overall percentage of bound tubular contents of Me203Hg+-L-cysteine
in the presence of probenicid, (98.7 %, P = 0.0934).
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Figure 17: The effect of probenicid on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic
contents, µM. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
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Figure 18: The effect of probenicid on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular
content expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of L-adepate on the basolateral transport of Me203Hg+-L-cysteine
Figure 19 shows the inhibition of the addition of 200 µM L-adepate to the bathing
solution along with 20 µM of Me203Hg+ and 22 µM of L-cysteine on the cell-to-bath ratios and
the cytosolic concentrations. The addition of L-adepate significantly reduced the cell-to-bath
uptake of Me203Hg+-L-cysteine by a factor of nine-fold (-4.5 ± 3.9, P = 0.0002). The contents of
the cytoplasm were -98.2 µM ± 84.7 in the presence of L-adepate, a significant reduction in
transport (P = 0.0001). The amount of Me203Hg+-L-cysteine bound to the tubule was also
significantly reduced by approximately 71 %, P = 0.0105 [Fig. 20]. Comparison of the
percentage of Me203Hg+-L-cysteine bound versus Me203Hg+-L-cysteine+adepate did not
demonstrate a statistically significant difference, P = 0.2060.
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Figure 19: The effect of L-adepate on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic
contents, µM. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
The “*” indicates a significant statistical difference, P≤0.05.
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Figure 20: The effect of L-adepate on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular
content expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of L-glutarate on the basolateral transport of Me203Hg+-L-cysteine
Addition of 200 µM L-glutarate to the bathing solution significantly reduced the transport
of Me203Hg+-L-cysteine at the basolateral membrane as noted in Figure 21 below showing the
cell-to-bath ratio (A) and the cytosolic contents (B). A three-fold reduction in cell-to-bath ratio
was noted (10.1 ± 2.4 versus 32.1 ± 5.2, P = 0.0023) and a 52 % reduction in the cytosolic
contents (237 µM ± 56.5 versus 496.8 µM ± 71.7, P = 0.0133). As noted in Figure 22, the
amount of bound Me203Hg+-L-cysteine at the tubular epithelium was reduced over two-fold
(4,925.4 fmol mm -1 ± 522.8 versus 11,107.8 fmol mm -1 ± 1,822.6, P = 0.0102). Comparing the
percentage of bound Me203Hg+-L-cysteine versus the percentage of bound Me203Hg+-L-cysteine
did not show a statistically significant difference (95 % versus 89.6 %, P = 0.1255).
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Figure 21: The effect of L-glutarate on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic
contents, µM. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
The “*” indicates a significant statistical difference, P≤0.05.
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Figure 22: The effect of L-glutarate on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular
content expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of L-methionine on the basolateral transport of Me203Hg+-L-cysteine
To determine whether L-methionine had an effect on the transport of the Me203Hg+-Lcysteine 200 µM was added to the bathing solution containing 20 µM Me203Hg+ and 22 µM Lcysteine. As seen in Figure 23 (A), the addition of L-methionine significantly reduced the cellto-bath ratio of Me203Hg+-L-cysteine when compared to Me203Hg+-L-cysteine transport alone
(14.3 ± 3.3 versus 32.1 ± 5.2, P = 0.0265). The concentration of the cytosol was also
significantly (265.7 µM ± 65.5, P = 0.0454) reduced in the presence of L-methionine as seen in
Figure 23 (B). The addition of L-methionine did not significantly increase the contents of the
tubule (12,572.4 fmol mm -1 ± 2,937.3, P = 0.6596). When comparing the percentage of tubular
contents between Me203Hg+-L-cysteine and Me203Hg+-L-cysteine+L-methionine a significant
increase was noted, 89.6 % and 98.7 % respectively (P = 0.0197) [Fig. 24].
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Figure 23: The effect of L-methionine on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic
contents, µM. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
The “*” indicates a significant statistical difference, P≤0.05.
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Figure 24: The effect of L-methionine on Me203Hg+-L-cysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular
content expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of L-methionine on the basolateral transport of Me203Hg+
To characterize the effect of L-methionine on the basolateral uptake of Me203Hg+, 20 µM
of Me203Hg+ along with 22 µM of L-methionine was added to the bathing solution. The average
cell-to-bath ratio and cytosolic contents of Me203Hg+-L-methionine at 12°C and 37°C are noted
in Figure 25. Bath-to-cell uptake of Me203Hg+-L-methionine (65.4 ± 12.7) was significantly
increased (P = 0.0201) at 37°C when compared to uptake of Me203Hg+-L-methionine at 12°C
(26.5 ± 4.0). The average cytosolic concentration of Me203Hg+-L-methionine at 12°C and 37°C
was 467.1 µM ± 64.6 and 890.2 µM ± 202.2 respectively, which was not a significant (P =
0.101) increase in the cellular contents. The amount of Me203Hg+-L-methionine at 12°C and
37°C bound to the basolateral epithelium of the tubule (fmol mm -1) and percentage of tubular
contents are noted in Figure 26. The amount of bound Me203Hg+-L-methionine complex at 37°C
was 11,794.6 ± 1,691.6 fmol mm -1 which is significantly (P = 0.0295) greater than the bound
Me203Hg+-L-methionine at 12°C was 6,852.4 ± 801.7 fmol mm -1. The percentage of bound
Me203Hg+-L-methionine complex at 12°C compared to the percentage of Me203Hg+-L-methionine
bound at 37°C was 94.3 % and 91.6 % (P = 0.3237), respectively.
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Figure 25: Me203Hg+-L-methionine transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each value
represents the mean ± SE with a minimum sample size of 5 tubules. The “*” indicates a
significant statistical difference, P≤0.05.
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Figure 26: Me203Hg+-L-methionine transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) tubular contents and (B) tubular content expressed as percentage of
total extracted. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
The “*” indicates a significant statistical difference, P≤0.05.
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The effect of PAH on the basolateral transport of Me203Hg+-L-methionine
Examination of the cell-to-bath ratios and cytosolic contents of the conjugate, Me203Hg+L-methionine (20 µM of Me203Hg+ and 22 µM of L-methionine), in the presence of 200 µM PAH
is shown in Figure 27. The addition of PAH to the bathing solution did not significantly reduce
the amount of Me203Hg+-L-methionine being transported from the bath-to-cell (31.6 ± 15.1, P =
0.3831) or the amount of cytosolic contents within the cell (543.3 µM ± 259.4, P = 0.4626).
Figure 28 shows the amount of bound Me203Hg+-L-methionine at the tubular epithelium was also
not significantly altered in the presence of PAH, (21,334.1 fmol mm -1 ± 12,630.9, P = 0.1517).
This also did not represent a statistically significant decrease in the overall percentage of bound
tubular contents of Me203Hg+-L-methionine in the presence of PAH, (90.9 %, P = 0.9056).
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Figure 27: The effect of PAH on Me203Hg+-L-methionine transport in the basolateral membrane
of the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents,
µM. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
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Figure 28: The effect of PAH on Me203Hg+-L-methionine transport in the basolateral membrane
of the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular content
expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules.
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The effect of L-taurine on the basolateral transport of Me203Hg+
To analyze the effect of L-taurine on the basolateral uptake of Me203Hg+, 20 µM of
Me203Hg+ along with 22 µM of L-taurine was added to the bathing solution. The average cell-tobath ratio and cytosolic contents of Me203Hg+-L-taurine at 12°C and 37°C are noted in Figure 29.
Bath-to-cell uptake of Me203Hg+-L-taurine (91.9 ± 16.9) was significantly increased (P = 0.0026)
at 37°C when compared to uptake of Me203Hg+-L-taurine at 12°C (7.8 ± 3.2). The average
cytosolic concentration of Me203Hg+-L-taurine at 12°C and 37°C was 106.8 µM ± 3.8 and
1,179.7 µM ± 210.4 respectively, demonstrating significantly (P = 0.0022) increased cellular
contents of Me203Hg+-L-taurine at normal physiological temperatures. The amount of Me203Hg+L-taurine at 12°C and 37°C bound to the basolateral epithelium of the tubule (fmol mm -1) and
percentage of tubular contents are noted in Figure 30. The amount of bound Me203Hg+-L-taurine
complex at 37°C was 15,523.2 ± 1,184.8 fmol mm -1 which is significantly (P = 0.0001) greater
than the bound Me203Hg+-L-taurine at 12°C was 4,211.3 ± 565.2 fmol mm -1. The percentage of
bound Me203Hg+-L-taurine complex at 12°C compared to the percentage of Me203Hg+-L-taurine
bound at 37°C was 97.8 % and 94 % (P = 0.008), respectively.
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Figure 29: Me203Hg+-L-taurine transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each value
represents the mean ± SE with a minimum sample size of 5 tubules. The “*” indicates a
significant statistical difference, P≤0.05.
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Figure 30: Me203Hg+-L-taurine transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) tubular contents and (B) tubular content expressed as percentage of
total extracted. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
The “*” indicates a significant statistical difference, P≤0.05.
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The effect of PAH on the basolateral transport of Me203Hg+-L-taurine, 37°C
Characterization of the effect of PAH at 37°C on the transport of Me203Hg+-L-taurine on
the cell-to-bath ratios and the cytosolic contents is shown in Figure 31. A significant reduction
in the cell-to-bath transport was noted in the presence of 200 µM PAH (A). Me203Hg+-L-taurine
transport was reduced by 23 % (20.6 ± 2.2, P = 0.0003). The amount of Me203Hg+-L-taurine in
the cytoplasm was also significantly reduced in the presence of PAH, 384.2 µM ± 40.5, P =
0.0009. As shown in Figure 32, the amount of bound Me203Hg+-L-taurine was substantially
reduced as well. The tubular contents of Me203Hg+-L-taurine+PAH compared to Me203Hg+-Ltaurine was -8,322.1 fmol mm -1 ± 847.3 versus 15,523.2 fmol mm -1 ± 1,184.8, P = 0.0001. The
percentage of bound Me203Hg+-L-taurine+PAH was significantly increased (P = 0.0001).
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Figure 31: The effect of PAH on Me203Hg+-L-taurine in the basolateral membrane of the S2
segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM (at
37°C). Each value represents the mean ± SE with a minimum sample size of 5 tubules. The “*”
indicates a significant statistical difference, P≤0.05.
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Figure 32: The effect of PAH on Me203Hg+-L-taurine transport in the basolateral membrane of
the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular content
expressed as percentage of total extracted (at 37°C). Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of PAH on the basolateral transport of Me203Hg+-L-taurine, 12°C
When 200 µM PAH was added to the bathing solution at 12°C, no significant reduction
in the cell-to-bath (12.8 ± 1.9, P = 0.2294) or cytosolic contents (224.2 µM ± 33.4, P = 0.0696)
were seen as noted in Figure 33. The amount of tubular contents and the percentage of tubule
contents was significantly reduced in the presence of 200 µM PAH, Figure 34. The tubular
contents decreased from 4,211.3 fmol mm -1 ± 565.2 to -7,839.9 fmol mm -1 ± 1,509.4, P =
0.0001. The percentage of bound Me203Hg+-L-taurine+PAH at the tubular epithelium was
significantly increased, 102.76 %, P = 0.0026.
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Figure 33: The effect of PAH on Me203Hg+-L-taurine transport in the basolateral membrane of
the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM
(at 12°C). Each value represents the mean ± SE with a minimum sample size of 5 tubules. The
“*” indicates a significant statistical difference, P≤0.05.
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Figure 34: The effect of PAH on Me203Hg+-L-taurine transport in the basolateral membrane of
the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular content
expressed as percentage of total extracted (at 12°C). Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of TEA on basolateral transport of Me203Hg+-L-taurine
To characterize the effect of TEA on the basolateral uptake of Me203Hg+-L-taurine, 20
µM Me203Hg+-L-taurine along with 22 µM TEA was added to the bathing solution. The average
cell-to-bath ratio and cytosolic contents of Me203Hg+-L-taurine-TEA at 37°C are noted in Figure
35. Bath-to-cell uptake of Me203Hg+-L-taurine-TEA (49.1 ± 4.9) was not significantly increased
(P = 0.1185) at 37°C when compared to uptake of Me203Hg+-L-taurine, alone (91.9 ± 16.9). The
average cytosolic concentration of Me203Hg+-L-taurine and Me203Hg+-L-taurine-TEA are 1,179.7
µM ± 210.4 and 1,145.2 µM ± 113.8 (P = 0.9172), demonstrating no significant increased in the
cellular contents of Me203Hg+ -L-taurine versus Me203Hg+-L-taurine -TEA at normal
physiological temperatures. The amount of Me203Hg+-L-taurine versus Me203Hg+-L-taurine TEA bound to the basolateral epithelium the tubular contents (fmol mm -1) and percentage of
tubular contents are noted in Figure 36. The bound Me203Hg+-L-taurine -TEA complex (6,988.1
± 2,820.5 fmol mm -1) was significantly less than the bound Me203Hg+-L-taurine (15,523.2 ±
1,184.8 fmol mm -1) (P = 0.0006). The percentage of bound Me203Hg+-L-taurine -TEA complex
compared to the percentage of Me203Hg+-L-taurine bound was 86.7 % and 94 % (P = 0.0005),
respectively.
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Figure 35: The effect of TEA on Me203Hg+-L-taurine transport in the basolateral membrane of
the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM.
Each value represents the mean ± SE with a minimum sample size of 5 tubules.
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Figure 36: The effect of TEA on Me203Hg+-L-taurine transport in the basolateral membrane of
the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular content
expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules.
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The effect of N-acetylcysteine on the basolateral transport of Me203Hg+
Figure 37 shows the effect of adding 22 µM N-acetylcysteine to the bathing solution
(12°C versus 37°C) on the cell-to-bath transport and the cytosolic contents of Me203Hg+. The
cell-to-bath ratio was significantly reduced by a factor of over seven-fold at 37°C (-16.4 ± 3.1
versus -2.2 ± 0.5, P = 0.0069). The contents of the cytosol were also significantly reduced when
comparing the amount of transport of Me203Hg+-N-acetylcysteine at 12°C versus 37°C, -28.5 µM
± 6.2 and -206.2 µM ± 37, P = 0.0051. Figure 38 shows the contents of the tubule containing
Me203Hg+-N-acetylcysteine and the percentage of tubular contents at 12°C versus 37°C. The
figure shows a significant difference between the amount of bound Me203Hg+-N-acetylcysteine at
the tubular epithelium 12°C versus 37°C, 433.2 fmol mm -1 ± 279.1 and 1,207.5 fmol mm -1 ±
153.9, P = 0.0143. However, the percentage of tubular contents was not statistically different (P
= 0.9737) between the two groups, 86.4 % and 82.3 %, respectively.
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Figure 37: Me203Hg+-N-acetylcysteine transport in the basolateral membrane of the S2 segments
of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each value
represents the mean ± SE with a minimum sample size of 5 tubules. The “*” indicates a
significant statistical difference, P≤0.05.
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Figure 38: Me203Hg+-N-acetylcysteine transport in the basolateral membrane of the S2 segments
of rabbit proximal tubules (A) tubular contents and (B) tubular content expressed as percentage
of total extracted. Each value represents the mean ± SE with a minimum sample size of 5
tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of PAH on the basolateral transport of Me203Hg+-N-acetylcysteine, 37°C
Characterization of the effect of PAH at 37°C on the transport of Me203Hg+-Nacetylcysteine on the cell-to-bath ratios and the cytosolic contents is shown in Figure 39. A
significant increase in the cell-to-bath ratio was noted in the presence of 200 µM PAH (A), 10.0
± 1.2, P = 0.0001. The amount of Me203Hg+-N-acetylcysteine in the cytoplasm was also
significantly reduced in the presence of PAH, 167.7 µM ± 20.7, P = 0.0001. As noted in Figure
40, the amount of bound Me203Hg+-N-acetylcysteine was substantially reduced as well. The
tubular contents of Me203Hg+-N-acetylcysteine+PAH compared to Me203Hg+-N-acetylcysteine
was -13,875.0 fmol mm -1 ± 1,518.4 versus 1,207.5 fmol mm -1 ± 153.9, P = 0.0001. The
percentage of bound Me203Hg+ N-acetylcysteine+PAH was not significantly changed (P =
0.8864).
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Figure 39: The effect of PAH on Me203Hg+-N-acetylcysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic
contents, µM. Each value represents the mean ± SE with a minimum sample size of 5 tubules.
The “*” indicates a significant statistical difference, P≤0.05.
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Figure 40: The effect of PAH on Me203Hg+-N-acetylcysteine transport in the basolateral
membrane of the S2 segments of rabbit proximal tubules (A) tubular contents and (B) tubular
content expressed as percentage of total extracted. Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.
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The effect of L-glutathione on the basolateral transport of Me203Hg+
Figure 41 shows the effect of adding 22 µM L-glutathione to the bathing solution
containing 20 µM Me203Hg+. There was no significant increase in either the cell-to-bath (-2.9 ±
0.6 and -2.8 ± 0.3, P = 0.9655) or the cytosolic contents (-47.9 µM ± 5.0 and -58.6 µM ± 8.2, P =
0.4341), at both 12°C and 37°C respectively. The amount of Me203Hg+-L-glutathione bound to
the tubule was significantly increased at 37°C, 1,267.8 fmol mm -1 ± 290.2, P = 0.0253 compare
to the amount presumably bound at 12°C, 128.9 fmol mm -1 ± 26 [Fig. 42].
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Figure 41: Me203Hg+-L-glutathione transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each value
represents the mean ± SE with a minimum sample size of 5 tubules.

86

A
30000
25000
20000
15000
10000

Me

203

Tubular Contents of
Hg+-L-Glutathione, fmol mm-1

35000

5000

*

0
12°C

37°C

Figure 42: Me203Hg+- L-glutathione transport in the basolateral membrane of the S2 segments of
rabbit proximal tubules (A) tubular contents. Each value represents the mean ± SE with a
minimum sample size of 5 tubules. The “*” indicates a significant statistical difference, P≤0.05.

The effect of DL-homocysteine on the basolateral transport of Me203Hg+
Figure 43 shows the effect of adding 22 µM DL-homocysteine to the bathing solution
containing 20 µM Me203Hg+. A significant increase in the cell-to-bath ratio (-5.2 ± 1 and -10.9 ±
2, P = 0.0427) and the cytosolic contents (-62.6 µM ± 22.7 and -143.5 µM ± 21.5, P = 0.0201),
was noted at both 12°C and 37°C respectively. The amount of Me203Hg+-DL-homocysteine
bound to the tubule was significantly increased at 37°C, 360.1 fmol mm -1 ± 62.6, P = 0.0003
compare to the amount bound at 12°C, 22.9 fmol mm -1 ± 18.6 [Fig. 44].
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Figure 43: Me203Hg+-DL-homocysteine transport in the basolateral membrane of the S2 segments
of rabbit proximal tubules (A) cell-to-bath ratio and (B) cytosolic contents, µM. Each value
represents the mean ± SE with a minimum sample size of 5 tubules. The “*” indicates a
significant statistical difference, P≤0.05.
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Figure 44: Me203Hg+- DL-homocysteine transport in the basolateral membrane of the S2
segments of rabbit proximal tubules (A) tubular contents. Each value represents the mean ± SE
with a minimum sample size of 5 tubules. The “*” indicates a significant statistical difference,
P≤0.05.
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Table 1 shows the outcome of Me203Hg+ mixed with rabbit whole blood and plasma. As
noted in the table, the concentration of Me203Hg+ is predominantly found with the protein pellet
(87% for whole blood and 98% for the plasma pellet). There is however about 1% of the
Me203Hg+ that remains in the supernatant.

Table 1: Concentration of Me203Hg+ in Plasma
Whole Blood
Blood pellet 86.99 ± 0.49 %
Plasma 13.01 ± 0.49 %
Supernatant 0.72 ± 0.03 %
Protein Pellet 99.27 ± 0.02 %
Plasma
Supernatant 0.94 ± 0.08 %
Protein Pellet 98.27 ± 0.21 %

Mass spectrometry analysis of only MeHgCl showed one dominant peak at 216.9 and one
small peak at 545.1 [Fig. 45]. Analysis of L-taurine alone also showed a dominant peak at 124
[Fig. 46] with two smaller ones at 97 and 212.1, while MeHgCl + L-taurine displayed a number
of peaks two were distinct, one at 251 and 409.1 [Fig. 47]. Mass spectrometry analysis of Lcysteine also had one discrete peak at 120 [Fig. 48] and the MeHgCl + L-cysteine conjugate had
several spikes with the predominant one at 409.2 [Fig. 49]. L-methionine showed one clear spike
at 150.2 [Fig. 50], while MeHgCl + L-methionine had numerous spikes, but one well-defined
409.2 [Fig. 51]. Figure 52 shows the mass spectrometry analysis of N-acetylcysteine with one
spike at 162 and MeHgCl + N-acetylcysteine has multiple spikes but four discrete peaks, with the
predominant ones at 212.1 and 378 [Fig. 53]. DL-homocysteine has a dominant spike at 136.1
[Fig. 54] and MeHgCl + DL-homocysteine shows numerous peaks, although two are more
distinct (113 and 212.1) in [Fig. 55]. L-glutathione has several smaller spikes and one dominant
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one at 306.1 [Fig. 56]. Figure 57 shows MeHgCl + L-glutathione with many spikes, several of
which are distinct (113, 172.1, 212.1 and 255.2). The mass spectrometry of plasma in a heparin
solution shows numerous spikes with the most distinctive one at 213.0 [Fig. 58]. Analysis of the
plasma after precipitation with a 20% TCA solution demonstrated one predominant spike at
160.9 [Fig. 59]. The addition of MeHgCl to the plasma TCA precipitate produced multiple
spikes with two dominant ones at 116.9 and 160.9 [Fig. 60]. Plasma was also analyzed in a NaCitrate solution and is shown in Figure 61-63. Figure 61 has two discrete peaks at 116.9 and 215
and the TCA precipitate of plasma in Na-Citrate also showed one predominant spike at 160.9
[Fig. 62]. The addition of MeHgCl to the plasma TCA precipitate again produced multiple peaks
with two distinct ones 116.9 and 160.9 [Fig. 63].
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Figure 45: Molecular ion MALDI-TOF mass spectrum of 20 µM MeHgCl in Millipore water.
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Figure 46: Molecular ion MALDI-TOF mass spectrum of 22 µM L-taurine in Millipore water.
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Figure 47: Molecular ion MALDI-TOF mass spectrum of 20 µM MeHgCl + 22 µM L-taurine
in Millipore water.
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Figure 48: Molecular ion MALDI-TOF mass spectrum of 22 µM L-cysteine in Millipore water.
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Figure 49: Molecular ion MALDI-TOF mass spectrum of 20 µM MeHgCl + 22 µM L-cysteine
in Millipore water.
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Figure 50: Molecular ion MALDI-TOF mass spectrum of 20 µM L-methionine in Millipore
water.
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Figure 51: Molecular ion MALDI-TOF mass spectrum of 20 µM MeHgCl + 22 µM Lmethionine in Millipore water.
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Figure 52: Molecular ion MALDI-TOF mass spectrum of 20 µM N-acetylcysteine in Millipore
water.
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Figure 53: Molecular ion MALDI-TOF mass spectrum of 20 µM MeHgCl + 22 µM Nacetylcysteine in Millipore water.
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Figure 54: Molecular ion MALDI-TOF mass spectrum of 20 µM DL-homocysteine in Millipore
water.
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Figure 55: Molecular ion MALDI-TOF mass spectrum of 20 µM MeHgCl + 22 µM DLhomocysteine in Millipore water.
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Figure 56: Molecular ion MALDI-TOF mass spectrum of 20 µM L-glutathione in Millipore
water.
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Figure 57: Molecular ion MALDI-TOF mass spectrum of 20 µM MeHgCl + 22 µM Lglutathione in Millipore water.
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Figure 58: Molecular ion MALDI-TOF mass spectrum of heparinized plasma.
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Figure 59: Molecular ion MALDI-TOF mass spectrum of heparinized plasma precipitated
with TCA.
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Figure 60: Molecular ion MALDI-TOF mass spectrum of MeHgCl in heparinized plasma
precipitated with TCA.
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Figure 61: Molecular ion MALDI-TOF mass spectrum of sodium-citrate plasma.
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Figure 62: Molecular ion MALDI-TOF mass spectrum of sodium-citrate plasma precipitated
with TCA.
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Figure 63: Molecular ion MALDI-TOF mass spectrum of MeHgCl in sodium-citrate plasma
precipitated with TCA.
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CHAPTER V: DISCUSSION
The purpose of the present study is to examine the characteristics of the transport systems
involved in the uptake of methylmercury and methylmercury conjugates at the basolateral
membrane of the rabbit renal proximal tubule.
Evidence for an active transport mechanism involved in the uptake of ionic
methylmercury was demonstrated by the effects of temperature. The transport of methylmercury
appears to be a temperature dependent process [Fig. 9, 10 A]. Reducing the temperature to 12°C
caused a significant percent decrease in the transport of methylmercury, thereby excluding the
possibility that the uptake of the heavy metal is due to diffusion through the lipid bilayer
membrane. Although there still appears to be some non-specific binding to the membrane [Fig.
10 A], this can not solely account for the significant increase in the uptake of Me203Hg+ seen in
the temperature dependent experiments.
Since the kidney plays an important role in clearing endogenous organic cations (OCs)
like acetylcholine, creatinine, dopamine and certain drugs such as, cimetidine, morphine, and
quinidine from the blood with the proximal tubule being the main site of OC secretion and
containing two organic cation transporters (OCT1 and OCT2), we investigated the possibility of
methylmercury being taken up at the basolateral membrane via an organic cation transporter
using tetraethylammonium which is considered to be a representative compound for transport by
the organic cation system. The addition of 22 µM TEA to the bathing solution did not
significantly decrease the uptake of methylmercury [Fig, 11, 12] thereby excluding transport of
methylmercury via an organic cation transporter.
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Methylmercury readily forms conjugates with thiol compounds in vivo because
methylmercury has a high affinity for sulfhydryl groups; therefore, metabolism and transport of
these derivatives are important determinants of tissue distribution and the elimination of
methylmercury from the body. In the present study, the bath-to-cell transport of methylmercuryL-cysteine conjugate (MeHg-S-Cys), methylmercury-L-methionine conjugate (MeHg-S-Met),
methylmercury-L-taurine conjugate (MeHg-S-Tau), methylmercury-N-acetylcysteine conjugate
(MeHg-S-NAC), methylmercury-L-glutathione conjugate (MeHg-S-GSH), and methylmercuryDL-homocysteine conjugate (MeHg-S-Hcys) were investigated as each of these compounds
contain either a thiol group or a sulfur atom [Fig. 64].
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Figure 64: Thiol-containing amino acids and amino acid derivatives.
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The molecular homology of these conjugates is very similar to the amino acid L-cystine
(Cys-S-S-Cys) suggesting that due to the structural similarity, the methylmercury-sulfhydryl
conjugates may in fact mimic L-cystine and compete for transport via the L-cystine transport
mechanism possibly through one of the basolateral amino acid transport systems (A or ASC).
The data from the current study support this hypothesis for the transport of the methylmercury-Lcysteine conjugate, the methylmercury-L-methionine conjugate, and the conjugate of
methylmercury-L-taurine.
In the basolateral membrane of the proximal tubule, several organic anion transport
mechanisms (OAT1, OAT2, OAT3) have been located. The organic anion transporters represent
the renal secretory mechanism for organic anions all of which are expressed in the kidney, while
some are also expressed in other tissues, such as the liver, brain and placenta. The organic anion
transporters are classified based upon their energy requirements, either Na+-independent
exchangers, primary active transporters requiring ATP hydrolysis, or Na+-dependent organic
anion transporters (Sekine et al, 2000). The Na+-independent exchangers and primary active
transporters have broad substrate selectivity, while the Na+-dependent transporter portrays a
relatively narrow substrate specificity (Sekine et al, 2000). OAT1 is a sodium-independent
transporter of PAH predominantly expressed in the basolateral membrane of the S2 segment of
the proximal tubule in the kidney. The organic anion transporter 2 (OAT2) is a Na+-independent
exchangers predominantly expressed in the liver and only mildly expressed in the kidney. OAT3
is expressed in a number of tissues, including the basolateral membrane of the proximal tubule in
the kidney, liver, brain and eye and shows the same diversity for substrates as OAT1.
Previous studies have demonstrated that inorganic mercury is taken up at the basolateral
membrane via OAT1 (Zalups and Ahmad, 2004) leading to the hypothesis that a methylmercury
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conjugate may also be transported in the basolateral via OAT1 as well. Uptake of Me203Hg+-Lcysteine was significantly decreased in the presence of PAH, a specific competitive substrate for
the renal organic anion transporters [Fig. 15] suggesting that the mercuric conjugate is indeed
being transported by the OAT system. Interestingly, the tubular contents of Me203Hg+-L-cysteine
conjugate were significantly increased in the presence of PAH [Fig. 16]. The addition of 200
µM probenicid, another competitive substrate and inhibitor of the organic anion transporters, to
the bathing solution decreased the amount of uptake in the basolateral membrane of the proximal
tubule, although the results were not statistically significant [Fig. 17]. However, the amount of
tubular contents bound to the membrane was significantly increased in the presence of
probenicid [Fig. 18]. These findings suggest that the primary mechanism of basolateral uptake
of organic mercury complexed to L-cysteine is indeed occurring through an organic anion
transport system.
There is current evidence suggesting that the organic anion transport systems are driven
by an organic anion/dicarboxylate acid exchange (Pritchard and Miller 1993). During normal
metabolic processes α-ketoglutarate is generated which contributes to an intracellular gradient
favoring the movement of this dicarboxylate out of the cell. As the amount of α-ketoglutarate
increases, it may be transported out of the cell in exchange for an organic anion at the organic
anion transporter. It has been implicated that the dicarboxylates that exit the proximal tubule cell
at the organic anion transporter may re-enter at the basolateral membrane via a Na+ or sodium
ion dicarboxylic acid cotransporter driven by the Na+ gradient generated from the Na+, K+
ATPase system (Pritchard and Miller 1993). Previous studies have shown that the basolateral
transport of inorganic mercury was inhibited by pretreatment with small aliphatic dicarboxylates,
such as glutarate or adepate (Zalups, 2000) suggesting that these dicarboxylates may create
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competition for the sodium-dependent entry of α-ketoglutarate. This would result in a decrease
in the uptake of any organic anions transported at the site of the organic anion exchanger and if
the organic form of mercury conjugated to L-cysteine is also being transported by this system, a
net decrease in the basolateral uptake of the mercuric conjugate would also be noted. Therefore
we postulated that the basolateral uptake of the organic form of the metal may also be inhibited
by these same dicarboxylates. The data demonstrated that both adepate and glutarate did indeed
create competition by decreasing the amount of glutamine (which is a source of α-ketoglutarate)
being transported at the dicarboxlyate exchanger thereby reducing the transport of the Me203Hg+L-cysteine conjugate at the site of the organic anion transporter and significantly decreasing the
rate of uptake at the basolateral membrane [Fig. 19, 20, 21, 22].
Further classification of the transport of Me203Hg+ conjugated to sulfhydryl containing
amino acids was examined using L-taurine. Taurine is a non-essential amino acid, which means
that it is manufactured from other amino acids in the liver, and is found in high concentrations in
the white blood cells, skeletal muscles, central nervous system and the heart muscles. Although
L-taurine does not contain a sulfhydryl group it does have a sulfur atom making it a potential
candidate for conjugating to Me203Hg+ in vivo. The data shows evidence for the active
basolateral transport of the Me203Hg+-L-taurine conjugate as demonstrated by a significant
increase in the transport indicated by the cell-to-bath ratio of Me203Hg+-L-taurine [Fig. 29] at
37°C compared to the uptake of the conjugate at 12°C. Furthermore, the total tubule contents of
Me203Hg+ were also significantly increased in the presence of L-taurine [Fig. 30] at normal
physiological temperatures suggesting some protein on the plasma membrane has a higher
affinity for the mercuric conjugate than just the organic metal by itself.
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Since L-taurine stimulated a significant increase in the basolateral uptake of Me203Hg+ we
also investigated the effect of PAH on the transport of this conjugate at both 37°C and 12°C. At
37°C, the addition of PAH significantly decreased the cell-to-bath ratio, cytosolic concentration
and the tubular contents [Fig. 31, 32] suggesting that not only is the Me203Hg+-L-taurine
conjugate likely being transported by the organic anion system, it is an active process and not
simply diffusing through the plasma membrane. When the bathing solution was cooled to 12°C
to eliminate any active transport processes, no further significant decreases in bath-to-cell
transport or the cytosolic concentration were seen [Fig. 33]. However, a significant reduction in
the amount of bound Me203Hg+-L-taurine conjugate was demonstrated [Fig. 34A] suggesting that
PAH interfered with the Me203Hg+-L-taurine conjugate from binding to the plasma membrane.
The amino acid, L-taurine, when bound to Me203Hg+ may be positively charged thereby
allowing uptake of the conjugate through one of the organic cation transport systems. To
investigate this possibility, 200 µM TEA was added to the bathing solution containing the
Me203Hg+-L-taurine conjugate. The data did not show a significant change in the cell-to-bath or
cytosolic concentration of this mercuric conjugate in the presence of TEA [Fig. 35] indicating
that the conjugate is probably not gaining entry in the basolateral via the organic cation transport
systems. A significant reduction in the bound Me203Hg+-L-taurine conjugate was seen [Fig. 36]
suggesting that the TEA molecule is in some way interfering with the binding of the mercuric
conjugate to the plasma membrane.
Another potential conjugate of Me203Hg+ for transport at the basolateral membrane is Nacetylcysteine. Previous studies have demonstrated an increased uptake of inorganic mercury
when co-administered with N-acetylcysteine and the addition of PAH inhibited this uptake
(Zalups and Barfuss, 1998) suggesting the organic form when conjugated to NAC may also
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demonstrate amplified uptake. The data from this study however did not show any increase in
the basolateral transport of Me203Hg-N-acetylcysteine conjugate [Fig. 37, 38], nor did the
addition of PAH to the bathing solution inhibit [Fig. 39, 40]. The finding that NAC was not
transported by the basolateral membrane of the proximal tubule is in direct correlation with
research demonstrating the chelating effect of NAC on methylmercury poisoning (Ballatori et al,
1998). In that study, NAC was shown to increase the urinary excretion of methylmercury and
decrease the tissue mercury levels. Therefore, we would not expect to see Me203Hg-NAC
conjugate being transported at the basolateral membrane of the proximal tubule.
The remaining potential conjugates of Me203Hg+ for transport at the basolateral
membrane that were examined are L-glutathione and DL-homocysteine. Glutathione being the
most abundant organic molecule in the cell and containing a free thiol group was hypothesized to
have a substantial effect on the transport of Me203Hg+. As the data clearly shows, virtually no
transport was seen with the addition of GSH to the bathing solution [Fig. 40, 41]. This same
phenomenon was also demonstrated when Hcys was conjugated to Me203Hg+ [Fig. 42, 43].
Therefore, it appears that these two conjugates of methylmercury are not involved in the
basolateral transport of methylmercury, but like NAC could add to excretion by increasing the
filtered load. A summary of the transport findings from this study is represented in Figure 65.
Analysis of Me203Hg+ in plasma obtained from rabbits showed nearly 99% of the
compound bound to some protein within the blood [Table 1]. However, approximately 1% of
Me203Hg+ in plasma is bound to some compound(s) within the supernatant which has yet to be
identified. Further examination of the supernatant was performed via molecular ion mass
spectrometry to isolate this unknown compound. Initial studies by mass spectrometry analysis
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were to confirm that the MeHg compound was combining with the amino acids studied in the
non-perfused tubule experiments.
Mass spectrometry of MeHgCl confirmed that the chloride ion is cleaved off when the
compound is in solution as the dominant peak was shown at 216.9 and the molecular weight of
MeHg+ is 251.08 with subtraction of the chloride ion leaving a formula weight of 216.08 [Fig.
45]. L-taurine has a molecular weight of 125.14 and the mass spectrometry output showed a
clear distinct peak at 124 indicating that L-taurine was being identified in solution [Fig. 46].
When MeHgCl was combined with L-taurine numerous peaks were identified [Fig. 47] with
spikes at 251 and 409.1, the latter being the more distinctive peak. The peak at 251 is indicative
of excess MeHgCl compound in solution. If MeHgCl (with the chloride ion being removed) is
combining with L-taurine we would have expected at spike at 341.22 which was not shown.
This means that some of the L-taurine is combining with MeHg, but not the entire intact
compound is forming a conjugate. L-taurine has a sulfur group bonded to two oxygen atoms and
a hydroxyl group [Fig. 64] along with two carbons and an amine group. Sulfur can form
anywhere from 1-6 bonds and the affinity of sulfur for mercuric compounds is on the order of
1015 – 1020 which is quite high suggesting the mercuric atom should displace either the hydroxyl
group or one or both oxygen. However, this combination does not coincide with mass
spectrometry peak of 409.1. Therefore, some form of two L-taurine compounds must be
combining with MeHg to form a conjugate as evidenced by the increase in transport of
Me203Hg+-L-taurine conjugate demonstrated in the non-perfused tubule studies described above.
L-cysteine has a molecular weight of 121.2 and the mass spectrometry output showed a
clear discrete spike at 120 indicating that L-cysteine was being identified in solution [Fig. 48].
When MeHgCl was combined with L-cysteine numerous smaller peaks were identified [Fig. 49]
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with the spike at 409.2 clearly standing out as distinctive spike. The MeHgCl + L-cysteine
conjugate should show a peak at 337.28 with the removal of the chloride ion. This again shows
that some form of L-cysteine is being conjugated with MeHg, but either the entire compound is
not binding or some form of multiple L-cysteine compounds are binding to MeHg possibly
forming a coordinate covalent bond as L-cystine does with the inorganic form of mercury (CysHg-Cys).
Figure 50 shows the mass spectrometry analysis of L-methionine which has a discrete
peak of 150.2 which is in direct correlation with the molecular weight of 149.2. When Lmethionine is combined with MeHgCl the mass spectrometry output shows several spikes, but
again the most discrete peak is at 409.2 [Fig. 51]. A one-to-one conjugation of L-methionine +
MeHg would yield a spike at 365.28, again assuming the chloride ion is removed, which is not
shown in the output. Therefore, some form of L-methionine must be combining with MeHg for
transport across the basolateral membrane of the renal proximal tubule cells as evidenced by the
non-perfused studies described above.
The three conjugates (L-cysteine, L-methionine and L-taurine) that demonstrated
transport within the basolateral membrane of the proximal tubule all produced distinctive peaks
at 409, none of which corresponded to a one-to-one conjugation with MeHg. Since each of these
amino acids contains a different combination of elements, it was postulated that something must
be occurring which is common to all three structures. The only possible construct which would
coincide with the mass spectrum is if all three amino acids are combining with MeHg as
-

HOOC -CH-CH2-S-Hg-S-CH2-CH-COOH- which would have a molecular weight of 408. This

compound would be in direct alignment with the results from the mass spectrum, but does
indicate that MeHg is being transported across the basolateral membrane with a negative charge
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as the inorganic form of mercury. The proposed negatively charged compound may explain why
MeHg appears to be transported by OAT and not OCT.
Mass spectrometry analysis of N-acetylcysteine produced one distinct peak at 162 which
is again in direct alignment with the molecular weight of 163.2 [Fig. 52]. The combination of
MeHgCl and N-acetylcysteine would be expected to produce a spike at 379.28 and Figure 53
demonstrates that this conjugate is forming as the most distinctive spike is occurring at 378. In
addition, MeHg has numerous naturally occurring isotopic forms which is confirmed in the mass
spectrometry as the peak at 378 shows various molecular weights of 376, 375 and 374 [Fig. 53].
This result confirms what is known in the literature that NAC has been effectively used as a
chelating agent in methylmercury poisoning, thereby confirming that NAC must be forming a
conjugate with MeHg.
Figure 54 shows the mass spectrometry analysis of DL-homocysteine with a discrete
spike at 136.1 which is complementary to the molecular weight of 135.2. When DLhomocysteine is combined with MeHgCl many spikes were produced, none of which correspond
to the expected formula weight of 351.28 if the combination was producing a 1:1 conjugate [Fig.
55]. Analysis of L-glutathione clearly showed the compound as the spike at 306.1 corresponds
to the formula weight of 307.3 [Fig. 56]. Figure 57 demonstrates that L-glutathione is
conjugating with MeHg as the mass spectrometry produced a 522.1 and the combined formula
weight would be expected at 523.38. It is not surprising that MeHg is conjugating with GSH due
to its high abundance in cells.
Figures 58 and 61 show plasma in either a heparin or Na-Citrate solution which produced
many peaks most likely corresponding to the various compounds found in blood. When the
plasma samples were then precipitated with TCA (molecular weight of 163.4) and analyzed
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many of the previous spikes were removed [Fig. 59 and 62]. However, both analyses showed the
TCA with a peak at 160.9. The addition of MeHgCl to both of the plasma TCA precipitates in
heparin [Fig. 60] and sodium-citrate [Fig. 63] were inconclusive. There was no clear spike
corresponding to the methylmercury conjugates (L-cysteine, L-methionine and L-taurine) that
demonstrated active transport at the basolateral membrane of the proximal tubule in the nonperfused tubule experiments described above. Further characterization of methylmercury
transport, in particular, what form of methylmercury is being excreted in the urine will need to be
examined to fully elucidate the conjugate being formed in vivo.
In conclusion, the current study clearly demonstrated that methylmercury could be
transported at the basolateral membrane of the S2 segment of the proximal tubule by multiple
mechanisms, depending on the form in which it is presented to the membrane. Figure 65 shows
that methylmercury may enter the renal epithelial cells from the basolateral membrane via either
the OAT system when conjugated to L-cysteine, L-taurine, or L-methionine or via the amino acid
transporter when conjugated to L-cysteine. This knowledge is the first step in understanding
how methylmercury gains access to the renal epithelial cells of the proximal tubule on the
basolateral membrane and will assist in the development of treatment strategies to prevent
methylmercury from gaining access and inducing toxicity.
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Figure 65: Diagram outlining the roles of the organic anion, dicarboxylate acids, and
amino acid transport systems in the basolateral uptake of methylmercury along the
proximal tubule. Intracellular generation of α-ketoglutarate (from normal metabolic
processes) generates a gradient which favors the movement out of the cell. If these
gradients are high enough, α-ketoglutarate will exit the cell in exchange for an organic
anion. Once out of the cell α-ketoglutarate may re-enter via exchange with sodium.
The driving force behind this exchange mechanism is the Na+, K+-ATPase located in
the basolateral membrane of the proximal tubule. As the diagram shows,
methylmercury enters the proximal tubule cell conjugated to L-cysteine, L-taurine, or
L-methionine via the organic anion transport system in exchange for intracellular αketoglutarate. The diagram also depicts adepate and glutarate compete with αketoglutarate at the site of the dicarboxylic acid transporter.
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